The effects of overexpression of lamin a and two mutants associated with premature aging on stem cell differentiation and proliferation. by Gibbs-Seymour, Ian
Durham E-Theses
The effects of overexpression of lamin a and two
mutants associated with premature aging on stem
cell differentiation and proliferation.
Gibbs-Seymour, Ian
How to cite:
Gibbs-Seymour, Ian (2007) The effects of overexpression of lamin a and two mutants associated with
premature aging on stem cell differentiation and proliferation., Durham theses, Durham University.
Available at Durham E-Theses Online: http://etheses.dur.ac.uk/2572/
Use policy
The full-text may be used and/or reproduced, and given to third parties in any format or medium, without prior permission or
charge, for personal research or study, educational, or not-for-profit purposes provided that:
• a full bibliographic reference is made to the original source
• a link is made to the metadata record in Durham E-Theses
• the full-text is not changed in any way
The full-text must not be sold in any format or medium without the formal permission of the copyright holders.
Please consult the full Durham E-Theses policy for further details.
Academic Support Office, Durham University, University Office, Old Elvet, Durham DH1 3HP
e-mail: e-theses.admin@dur.ac.uk Tel: +44 0191 334 6107
http://etheses.dur.ac.uk
The oopyrigbt of this thesis rests with tbe 
autbor or the university to wbich it was 
submitted. No quotation from il, or 
information derived from it may be 
published without the prior written 
oonsent of tbe author or universily, and 
any in(ol'!l)ation derived from it should be 
acknowledged . 
•• ,,Durham 
University 
Department of Biological & Biomedical Sciences 
The Effects ofOverexpression ofLamin A and Two 
Mutants Associated With Premature Aging On Stem Cell 
Differentiation And Proliferation. 
Ian Gibbs-Seymour 
Professor C J Hutchison and Professor C A B Jahoda 
A dissertation in partial fulfillment of the regulations governing the Degree 
of Master of Science in Cell Biology, of Durham University 
Faculty of Science September 2007 
- lt JUN 2008 
Abstract 
The nuclear lamina is composed of A and B-type lamins and performs a number of 
functions within the nucleus. Mutations within lamins give rise to a group of diseases 
called laminopathies including autosomal dominant Emery-Dreifuss muscular dystrophy 
and lipodystrophy. Hutchinson Gilford Progeria Syndrome (HGPS), or so-called 
premature aging, is a rare and devastating laminopathy disorder caused by mutations in 
LMNA that leads to the production of a truncated mutant form of prelamin A, called 
progerin or LM50, that cannot undergo proteolytic processing to yield mature lamin A. 
In an atypical form of HGPS, a point mutation at amino acid 644 alters the Zmpste24 
endoproteolytic cleavage site, causing the production of mutant prelamin A. Why and how 
these prelamin A mutants cause such devastating phenotypes is not fully understood. It 
has been suggested that the mutant prelamin A may affect the ability of adult stem cells to 
self-renewal and differentiate, which are essential processes in order to replace damage of 
old tissues, critical for organismallongevity. Herein, expression plasmids containing two 
mutations found in classical and atypical HGPS were transiently overexpressed in clonal 
rat dermal papilla (DP) 9 cells, which, in vivo, reside at the base of the hair follicle and 
play an important role in hair follicle cycling. DP9 cells showed an increased number of 
nuclear abnormalities compared to control cells, which have previously been shown to be 
characteristic of cells from HGPS patients. DP9 cell lines stably overexpressing either 
FLAG-prelamin A, FLAG-prelamin A~50 or FLAG-prelamin A(R644C) were created. To 
assess the ability of the stem cells to self-renew, stable cell lines were routinely passaged 
and counted. Results indicate that stable overexpression of FLAG-prelamin A~50 and 
FLAG-prelamin A(R644C) inhibits the ability of stem cells to self-renew in vitro. 
Previous reports have shown that DP9 cells may be directed towards both adipogenic and 
osteogenic lineages. Therefore, in this study, stable DP9 cell lines expressing FLAG-
prelamin A, FLAG-prelamin M50 or FLAG-prelamin A(R644C) were exposed to an 
adipogenic medium for six days. Results showed that overexpression of FLAG-prelamin 
A, FLAG-prelamin A~50 and FLAG-prelamin A(R644C) inhibited the accumulation of 
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intracellular lipids, reflecting a decreased ability to differentiate in vitro. Taken together, 
these results suggest the lipodystrophy and alopecia associated with HGPS may be due to 
the failure of adult stem cell populations within each tissue to both self-renew and 
differentiate, and may underpin the disease pathogenesis. Furthermore, these results have 
implications for other laminopathies that produce mutant prelamin A. 
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Chapter 1. Introduction 
The Nucleus 
The nucleus is the hallmark of all eukaryotic cells and served as the first evolutionary step 
towards multicellularity (Verstraeten et al., 2007). This complex dynamic organelle is 
built around a three-dimensional interphase chromatin structure that serves as the building 
block of its own environment, i.e. a functional nucleus, and is responsible for a vast array 
of functions (Qumsiyeh, 1999). During interphase these functions include RNA 
production, DNA replication and the bi-directional transport of macromolecules (Lamond 
and Earnshaw, 1998; Cardoso et al., 1999; Qumsiyeh, 1999). As the nucleus is built 
around chromatin, the inner nuclear membrane provides a physical attachment point to 
segregate chromatin into highly specific and defined chromosomal territories (Marshall et 
al., 1997). Furthermore, the nucleus provides specific structural platforms to aid 
regulatory factors to control the transcription of genes. The nuclear envelope (NE) also 
acts as a physical barrier between the nucleoplasm and the cytoplasm, thus separating 
various metabolic processes and also preventing the translation of unspliced mRNA; this 
compartmentalisation adds a level of regulation required for complex organisms (Pennisi, 
2004; Manset al., 2004; Jekely, 2005). The nucleus is perforated by protein channels that 
allow the import and export of molecules into and out of the nucleus (Gorlich and Kutay, 
1999). This has important consequences in terms of signalling mechanisms that serve to 
either activate or repress gene transcription, and thus the nucleus also functions to control 
these signalling cascade events that result in an information exchange between nucleus 
and cytosol (Hansson et al., 2004; Hayden and Ghosh, 2004). 
The structure of the nucleus comprises an internal nucleoplasm surrounded by a double 
membrane, the two components of which being the inner nuclear membrane (INM) and 
the outer nuclear membrane (ONM) (Figure 1) (Maidment and Ellis, 2002; Worman and 
Courvalin 2005). 
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Figure 1. Overview of the structure of the nuclear envelope. (See text for details, 
Maidment and Ellis, 2002) 
Whilst the INM contains a unique set of proteins, the ONM is contiguous with the rough 
endoplasmic reticulum (RER) and thus shares a similar protein content. This double 
membrane creates a perinuclear space that is an extension of the ER lumen (Burke and 
Stewart, 2006). The double membrane is punctuated by a multi-protein complex called the 
nuclear pore complex (NPC) that tightly controls transport between the nucleoplasm and 
cytoplasm (Gerace and Burke, 1988; Gorlich and Kutay, 1999). Each NPC is evenly 
distributed around the nuclear envelope and consists of approximately 30 proteins called 
nucleoporins that are collectively assembled in a modular fashion (Cranshaw et al., 2002; 
Lim and Fahrenkrog, 2006). As well as integral nucleoporins such as grp21 0 and 
POM121, there are nucleoporins that are unique to both the nucleoplasmic and 
cytoplasmic face of the NPC. On the nucleoplasmic face, the N up 107-160 complex binds 
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to the basket nucleoporin, Nup153, whose incorporation upon nuclear envelope re-
assembly is dependent on a functional nuclear lamina (Smythe et al., 2000; Maeshima et 
al., 2006). Transport through the NPC is the subject of some debate whilst the NPC has 
also been shown to be involved in gene activation/repression (Bayliss et al., 2000; Rout et 
al., 2000; Ribbeck and Gorlich, 2001; Dilworth et al., 2001; Rout et al., 2003). 
Underlying the inner nuclear membrane is a filamentous meshwork called the nuclear 
lamina, containing A and B-type lamins and lamin-binding proteins (Burke and Stewart, 
2002; Hutchison, 2002; Hutchison and Worman, 2004; Gruenbaum et al., 2005; Broers et 
al., 2006; Burke and Stewart, 2006). 
Outer Nuclear Membrane and Perinuclear Space 
Previously, it had long been believed that since the ONM and RER both share ribosomes 
and are continuous then it follows that they should have an identical protein composition 
(Broers et al., 2006). However, several lines of evidence suggest that they are quite 
distinct in protein composition with proteins found in the ONM that are not found in the 
bulk ER. Furthermore, the proteins in the ONM and INM have been shown to interact and 
this has led to the proposal of a novel nucleo-cytoskeletal link via the perinuclear space 
(PNS), with repercussions for nuclear position and anchorage (Figure 2) (Zhang et al., 
2001; Zhen et al., 2002; Starr and Han, 2003; Padmakumar et al., 2004). 
The precedent for a mammalian nucleo-cytoskeletallink via the PNS was based largely on 
research into Caenorhabditis elegans. Mutation within the C.elegans UNC-84 protein 
identified it as having a non-specific effect on both neural and non-neural cell lineages 
during development and being responsible for correct nuclear migration and anchoring 
(Horvitz et al., 1983; Malone et al., 1999). The same group then showed that this protein 
was located at the INM, with its location dependent on the single C.elegans lamin for 
correct retention at the INM (Malone et al., 1999; Lee et al., 2002). The C-terminal of 
UNC-84 extends into the PNS and shares a degree of similarity with the 
Schizosaccharomyces .pombe .. SadL-pro.tein'"· that is. r,equired __ for __ .functional _spindle __ 
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architecture and anchors the spindle pole body to the nuclear envelope (Hagan and 
Yanagida, 1995; Malone et a!., 1999). Comparable mammalian proteins that shared 
similarity to this -200 amino acid C-terminal region were termed SUN proteins 
(~ad!UNC-84 homology) (Malone eta!., 1999). That an INM protein could have effects 
on nuclear positioning and anchorage led to the suggestion that the INM and ONM were 
connected via the PNS, and indeed evidence for this was first reported for defects in the 
ANC-1 protein of C.elegans (Starr and Han, 2002). ANC-1 is a conserved type II ONM 
protein responsible for anchoring the nucleus to the actin cytoskeleton as well as being 
responsible for the correct position of mitochondria, and is dependent on UNC-84 for 
correct localisation at the ONM (Starr and Han, 2002; Starr and Han, 2003). Further work 
evidenced that another ONM protein, UNC-83, which is spatially and temporally 
controlled through development, was also required for proper nuclear anchoring and 
migration and interacts with UNC-84 via a conserved domain in the PNS and may act to 
connect microtubules to the nucleus (Starr eta!., 2001; Starr and Han, 2003; McGee eta!., 
2006). Taken together, this is the first evidence showing that resident proteins of the ONM 
and INM may interact via lumenal domains across the PNS, providing a structural link 
between the nucleus and the cytoskeleton. 
ANC-1 is homologous to a group of proteins that are conserved within mammals and are 
now collectively referred to as nesprins (Starr and Han, 2003). Although nesprins may 
v~ry in size with alternatively spliced variants ranging from 50kDa to 1MDa, they share 
some notable characteristic features. Firstly, they contain multiple spectrin repeats 
sequences, which have been previously described for other large structural proteins such 
as dystrophin and a-actinin (Apel et a!., 2000; Zhang et a!., 2001; Zhen et a!., 2002; 
Young and Kothary, 2005; Zhang et a!., 2005). These spectrin repeat sequences are 
distributed throughout the central core domain of the protein, enabling self-interaction 
between polypeptides (Mislow et a!., 2002a). The N-terminal contains an actin-binding 
domain (ABD) composed of two calponin homology domains, whilst the C-terminal 
contains a conserved 60 amino acid functional domain (Worman and Gundersen, 2006). 
This C-terminal domain has been termed a KASH (Klarsicht, ANC-1, ~e Homology) 
13 
domain and contains a transmembrane segment as well as functioning in intermediate 
filament binding and microtubule binding (Starr and Han, 2003). 
Nesprins-1 ,2 and 3 are coded for by three genes in mammals and have a variety of names 
within the literature: CPG2, syne-1, myne-1, ENAPTIN (nesprin-1) and syne-2, NUANCE 
(nesprin-2) (Apel et al., 2000; Zhang et al., 2001; Zhen et al., 2002; Wilhelmsen et al., 
2005; Zhang et al., 2005; Burke and Stewart, 2006; Worman and Gundersen, 2006). 
Nesprin-1 and 2 are extremely large proteins, of -976 kDa and -764 kDa respectively, and 
are located at the ONM. Nesprin-3 is similarly located at the ONM, but smaller at -110 
kDa and is distinct from both nesprin-1 and 2 as it binds plectin at its N-terminal rather 
than actin (Wilhelmsen et a!., 2005). Nesprins-1 and 2 also express a large number of 
splice variants, some of which do not contain the actin-binding domain and/or the KASH 
domain (Mislow eta!., 2002a; Cottrell et a!., 2004; Padmakumar et a!., 2004; Zhang eta!., 
2005). One variant, nesprin-1a is localised to the INM where it binds both laminA and C 
and emerin in vitro and in vivo, with a possible function in helping to organise the 
nucleoskeleton via binding to nuclear actin (Mislow et al., 2002a,b; Libotte et al., 2005; 
Wilhelmsen et al., 2005; Zhang et al., 2005; Broers et al., 2006; Wilhelmsen et al., 2006). 
The localisation of nesprins to either the INM or ONM is largely dependent on the size of 
the splice variant because whilst the smaller isoforms (< 60kDa) are able to passively 
diffuse from the· bulk ER past the NPC and localise to the INM, the larger isoforms are 
exempt from this membrane due to the restricted size of the lateral channels of the NPC 
and instead reside within the ONM (Soullam and Worman, 1995; Worman and 
Gundersen, 2006). Tethering of the larger nesprin-1 and 2 isoforms and nesprin-3 at the 
ONM occurs through SUNl/2, mammalian homologues of UNC-84 via binding to the 
KASH domain (Fridkin et al., 2004; Hodzic et al., 2004; Padmakumar et al., 2005; Crisp 
et al., 2006; Padmakumar et al., 2006). That both SUN1 and SUN2 are able to carry out 
this tethering function of giant nesprins suggests a redundant functionality of both 
proteins, with the interaction complex now being termed the LINC (Linker of 
Nucleoskeleton and ~oskeleton) complex (Figure 2) (Crisp et al., 2006). 
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The vanous nesprin isoforms have multiple functions including regulating myotubal 
nuclear clustering at neuromuscular junctions, targeting the muscle A-kinase anchoring 
protein (MAKAP) to the nuclear envelope in cardiomyoctes and regulating the 
endocytosis of glutamate receptors in the brain (Apel et a/., 2000; Cottrell et al., 2004; 
Pare et al., 2005; Zhang et al., 2007) (reviewed in Wilhelmsen et al., 2006). Additionally, 
it has recently been shown that mutations within nesprin-1 lead to an autosomal recessive 
form of cerebellar ataxia (OMIM 610743) (Gros-Louis eta/., 2007). 
The perinuclear space (PNS) between the INM and ONM has been considered identical to 
the continuous ER lumen. However, hypothetically, as the RER and ONM differ in 
protein composition then logically it may be suggested that the composition of the PNS 
could differ from the bulk ER lumen as portions of INM proteins localized to the INM and 
NPCs within this lumenal region could bind to resident non-membrane proteins (Worman 
and Courvalin, 2005). Indeed, mutations in an ATPase called torsinA that causes early-
onset AD dystonia, causes the protein, normally a lumenal ER protein, to concentrate in 
the PNS where it has been found to bind preferentially to the INM protein LAP1 (OMIM 
605204) (Senior and Gerace, 1988; Gonzalez-Alegre and Paulson, 2004; Goodchild and 
Dauer, 2004; Naismith et a/., 2004; Goodchild and Dauer, 2005). The disease is 
characterized by the involuntary twisting movements of the patient as a result of neuronal 
dysfunction. How the altered protein-protein interaction between torsinA and LAP1 
contributes to the disease phenotype is not yet understood, however, some have suggested 
that it may alter protein-protein interactions in the PNS, therefore, having a more global 
effect on nuclear positioning, a suggestion reinforced by work in both Drosophila and 
C.elegans (Basham and Rose, 2001; Gerace, 2004; Koh et al., 2004). 
Inner Nuclear Membrane 
The constituent proteins of the inner nuclear membrane are responsible for a variety of 
essential cellular functions ranging from cell signalling, gene regulation and enzymatic 
activity (Ye and Worman, 1996; Imai. et. al., 1997; Markiewicz et al., 2006). A full 
15 
characterisation of the nuclear envelope composition in different tissues was deemed 
necessary in order to fully understand tissue-specific diseases that arise from mutations 
within nuclear envelope proteins (Figure 2) (Schirmer et a!., 2003) A comparative 
proteomics approach had previously identified 7 out of 10 known nuclear envelope 
transmembrane proteins (NETs) (Dreger et al., 2001). A more refined subtractive 
proteomics approach using purified rat liver tissue identified all 13 known NETs and a 
further putative 67 NETs (Schirmer et al., 2003). This approach revealed significant 
differences in NE composition between different tissue types, with some new NETs 
exhibiting a 10-fold difference in expression between tissues (Schirmer et al., 2003; 
Schirmer and Gerace 2005). As yet it is unclear as to the function of each of these proteins 
but future work will determine this. Furthermore, it would seem that mutations in these 
proteins are more than likely to contribute to human disease given the nature of currently 
known INM proteins and their role in disease and thus elucidating the function of these 67 
proteins may provide novel insights into helping solve the underlying pathogenesis of 
diseases that arise through mutations in nuclear envelope proteins (discussed later) 
(Schirmer and Gerace, 2005; Wilkie and Schirmer, 2006). One clue comes from the 
finding that some NETs are differentially upregulated during myogenesis, suggesting that 
this may be the case for differentiation of other cells and though this remains to be tested 
is an intriguing possibility (Chen et al., 2006). 
INM proteins are firstly synthesised in the RER with at least one transmembrane (TM) 
domain (Worman and Courvalin, 2005). Thereafter they are subject to INM localisation 
due to the 'selective retention model' of protein targeting whereby proteins of less than 60 
kDA may laterally diffuse past the NPC into the INM where they can bind to the 
underlying nuclear lamina or chromatin (or both) components (Powell and Burke, 1990; 
Soullam and Worman, 1993; Soullam and Worman, 1995; Ellenberg et al., 1997; Ostlund 
et al., 1999; Wu et al., 2002; Ohba et al., 2004). This model is non-selective and 
discriminates only against the size of the protein. Furthermore, it has been suggested that a 
degree of remodeling of the NPC may be necessary in order to allow the passage of the 
proteins from the ONM to the INM as the process is energy dependent (Ohba et al., 2004). 
:::>. This study also disqualified other hypotheses including ··vesicle fusion and soluble 
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transport mechanisms (Ohba et al., 2004). Entry of yeast INM orthologues to the nucleus 
directly through NPC channels has recently been reported (King et al., 2006). These 
proteins contained basic sequence motifs that resembled nuclear localisation sequences 
(NLSs) with their import reliant upon karyopherin-a, karyopherin-~1 and the Ran-GTPase 
cycle, drawing obvious similarities between this and the import of soluble nuclear proteins 
(King et al., 2006; Lusk et a!., 2007). Since most mammalian INM proteins contain an 
NLS-like sequence it may prove that an active NPC-mediated import of INM proteins 
works alongside the selective-retention model (Horton and Nakai, 1997; Vaughan et al., 
2001; Wu et al., 2002; King et al., 2006; Ostlund et al., 2006). Phosphorylation of INM 
proteins at the start of mitosis causes them to detach from the underlying nuclear lamina 
and chromatin and diffuse to the ER, allowing for correct concomitant NE disassembly. 
However, INM proteins are selectively targeted to the decondensing chromatin in 
daughter cells to form the new NE prior to lamina assembly (Courvalin et al., 1992; 
Chaudhary and Courvalin, 1993; Foisner and Gerace, 1993; Buendia and Courvalin, 1997; 
Ellenberg et al., 1997; Yang et al., 1997; Ellis et al., 1998; Haraguchi et al., 2000). 
Lamina B Receptor (LBR) 
The lamin B receptor (LBR) is a 58 kDa INM protein identified by a biochemical screen 
for lamin-binding proteins in a lamin-depleted NE fraction (Worman et al., 1988). It was 
found to preferentially bind lamin B 1 over lamin A, with antibodies raised against it 
revealing a nuclear envelope staining (Worman et al., 1988). Subsequent analysis revealed 
that LBR has a basic N-terminal domain of -200 amino acids that faces the nucleoplasm, 
which interacts with B-type lamins, LAP2~, the heterochromatin proteins 1 (HP 1) a and y, 
histones H3/H4 and heterochromatin (Worman et al., 1988; Ye and Worman, 1994; Ye 
and Worman, 1996; Ye eta!., 1997; Holmer et al., 1998; Duband-Goulet and Courvalin, 
2000; Polioudaki et al., 2001; Makatsori et al., 2004). This is followed by a hydrophobic 
region containing eight putative TM domains (Worman et al., 1990; Schuler et al., 1994; 
Ye and Worman, 1994). The C-terminal domain is -400 amino acids and shares sequence 
similarity to conserved sterol reductases, an enzyme that catalytically converts cholesta-8, 
• •··•~v --,.;.•· ,,,:,.,.,,_ ·'-· .,._,.- ... ,. .• lr',,·~··~ .... -o.·•··-<·----:-• -,~' 
14-dien-3~-ol, to cholesterol, with expression ofhLBR in yeast confirming this C14-streol 
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reductase activity (Holmer eta/., 1998; Silve et al., 1998; Waterhan et al., 2003). LBR is 
essential for fetal development and has an important role in targeting membranes to the 
NE assembly post-mitosis (Pyrpasopoulou et al., 1996; Ellenberg et al., 1997; Haraguchi 
et al., 2000; Waterham et al., 2003). Mutations in LBR give rise to two distinct diseases, 
Pelger-Huet anomaly (PHA; OMIM 169400) and Hydropsectopic calcification-moth eaten 
(HEM) or Greenberg skeletal dysplasia (OMIM 215140) (Hoffmann et al., 2002; Best et 
al., 2003; Waterham et al., 2003). PHA is characterized by abnormal nuclear shape and 
chromatin organisation in blood granulocytes and may be inherited either as an AD or AR 
trait (Hoffmann et al., 2002). HEM/Greenberg skeletal dysplasia is an AR 
chondrodystrophy with a lethal course, characterized by short limbs and abnormal bone 
calcification (Waterham et al., 2003). Cultured fibroblasts exhibit increased levels of 
cholesta-8, 14-dien-3~-ol in line with the sterol reductase ability of LBR and it has been 
proposed that the nature of the mutation, ether heterozygous and homozygous, is the 
ultimate determinant of the disease phenotype (Waterham et al., 2003; Worman and 
Courvalin, 2005). 
Emerin 
Emerin is a 34 kDa type II integral INM protein encoded by the gene EMD (initially 
called STA) located by positional cloning to the X chromosome (Bione et al., 1994; 
Manilal eta!., 1996; Nagano et al., 1996). Emerin has a nucleoplasmic N-terminal domain 
of 220 amino· acids, a single TM domain and a short C-terminal domain in the PNS 
(Manilal et al., 1996; Nagano et al., 1996). Sequences in the nucleoplasmic domain 
mediate its inner nuclear membrane retention (Ostlund et al., 1999; Tsuchiya et al., 1999). 
The nucleoplasmic domain is responsible for binding lamins A and C, interactions that are 
either directly or indirectly responsible for its INM localisation (Ellis et al., 1997; Fairley 
et al., 1999; Sullivan et al., 1999; Clements et al., 2000; Rahatjo et al., 2001; Sakaki et 
al., 2001; Vaughan et al., 2001; Libotte et al., 2005). Emerin is one of a number of 
proteins that contains a conserved 43 amino acid folded motif called an LEM (1AP2, 
Em_erin,.)vlANJ) J!()lll~in ne~r i!s N:-te_rmiAus facing the nucleoplasm (Lin et al., 20QO; 
Zheng et al., 2000; Cai et al., 2001; Laguri et al., 2001; Wolff et al., 2001). It is believed 
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that this domain allows certain overlapping functions between all LEM-domain containing 
proteins, for example, RNAi of either Ce-MAN1 or Ce-emerin allows 85% viability in 
C.elegans, whilst RNAi of both leads to 100% lethality (Liu et al., 2003). Similarly, 
emerin is dispensable for cell survival and normal development (Harborth et · a!., 2001; 
Gruenbaum et al., 2002). The LEM-domain binds to a variety of proteins: the chromatin-
associated protein barrier-to-autointegration factor (BAF); the transcription factor germ 
cell-less (GCL), which binds to the DP3 subunit of E2F-DP heterodimeric transcription 
factors thus blocking E2F-DP-dependent gene expression; the death promoting 
transcriptional repressor Btf; the transcriptional regulator Lmo7; the splicing factor 
YT521-B (Lee et al., 2001; Nili et al., 2001; Holaska et al., 2003; Wilkinson et al., 2003; 
Bengtsson and Wilson, 2004; Haraguchi et al., 2004; Mansharamani and Wilson, 2005; 
Holaska et al., 2006; Margalit et al., 2007). The C-terminal domain of emerin also 
contains a conserved adenomatous polyposis coli (APC) consensus sequence capable of 
binding ~-catenin, a developmentally important downstream effector in the Wnt-signalling 
pathway (Markiewicz eta/., 2006). Together, these interactions suggest a diverse role for 
emenn as a scaffold protein capable of regulating chromatin structure and gene 
transcription. 
Emerin is mutated in X-linked Emery-Dreifuss muscular dystrophy, which is 
characterised by progressive muscle wasting, shortening of tendons, and heart and 
conduction system defects (X-EDMD; OMIM 310300) (Bione et al., 1994; Manila! eta/., 
1996; Nagano et al., 1996). Most mutations cause a reduction or complete loss of emerin 
with mislocalisation to the ER in some cases (Nagano et al., 1996; Manila! eta/., 1998; 
Fairley et al., 1999; Ellis et al., 2000; Niebroj-Dobosz et a/., 2003). Furthermore, this 
alters the interaction between emerin and A-type lamins, causing in increased solubility of 
both A and B-type lamins (Markiewicz et al., 2002a). 
Recent proteomic analysis of binding partners for emerin in HeLa cell confirms that it 
exists in distinct protein complexes (Holaska and Wilson, 2007). One of these is a nuclear 
myosin !-containing complex that might sense and regulate mechanical tension at the 
· .nuclear · envelope {Holaska···,et .a/;, 2001.);- Indeed, emerin null cells have impaired 
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mechanotransduction ability (Lammerding et al., 2005). Additionally, emerin null cells 
have abnormally shaped nuclei with membrane and chromatin protrusions and exhibit 
accelerated growth rate with increased rates of apoptosis (Fidzianska et al., 1998; 
Markiewicz et al., 2006; Meabum et al., 2007). The increased growth rate of emerin null 
cells is due to increased accumulation of active nuclear ~-catenin (Markiewicz et a!., 
2006). Overexpression of emerin restricts ~-catenin to the cytoplasm inhibiting the 
activation of the Wnt-pathway (Markeiwicz et al., 2006). Further to this, gene-profiling of 
cells from both patients and emerin null mice have shown that myoblast differentiation is 
delayed as compared to control cells, explained by a disruption to the transcriptional 
pathways regulated by MyoD and Rb (Bakay et al., 2006; Melcon et al., 2006; Ozawa et 
al., 2006). Gene expression profiling of hearts taken from EMD null mice shows an 
activation of MAPK signalling pathway and downstream targets implicated in the disease 
pathogenesis (Muchir et a!., 2007). Taken together, these results provide a basis for 
understanding the phenotypic characteristics ofX-EDMD. 
Lamina-Associated Proteins (LAPs) 
Another member of the LEM-domain containing group of proteins is the increasingly 
diverse lamina-associated proteins (LAPs) (Senior and Gerace, 1988; Foisner and Gerace, 
1993). LAPs were initially identified based on their resistance to biochemical extraction 
and identified as INM proteins by monoclonal antibodies (Senior and Gerace, 1988; 
Foisner and Gerace, 1993; Gerace and Foisner, 1994). The LAP1 family of proteins are 
derived from alternative splicing of the LAPJ gene, which codes for LAP1A, B and C 
(Foisner and Gerace, 1993). LAP1 is a 75 kDa type II integral INM protein, whilst LAP1B 
and C are 68 and 57 kDa respectively, and all share the same TM and lumenal domains 
(Foisner and Gerace, 1993; Martin et al., 1995). All three isoforms are expressed in a 
developmentally regulated manner and bind both A and B-type lamins (Martin et al., 
1995; Maisonet al., 1997). 
In contrast, t~ere are six isofolllls of the aJ!ematively spliced LAP2 gene, namely LAP2a, 
~. y, 8, £, and S· LAP2~, y, 8 and£ are all type II integral INM proteins that contain a long 
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N-terminal nucleoplasmic domain followed by a single TM domain and a short C-terminal 
lumenal domain. In contrast, LAP2a and ~ do not contain TM domains, and while LAP2~ 
does share the first 219 N-terminal amino acids of LAP2~, y, ()and£, LAP2a contains a 
unique C-terminal region (Harris eta!., 1994; Furukawa et al., 1995; Harris et al., 1995; 
Berger et al., 1996; Yang et al., 1997; Gant et al., 1999; Dechat et al., 2000a,b). LAP2~ is 
the largest TM LAP2 that binds preferentially to lamin B 1 via a lamin B 1 binding domain 
between amino acids 298 and 370, with the interaction between LAP2~ and lamin B1 
responsible for its INM localisation (Foisner and Gerace, 1993; Furukawa et al., 1995; 
Furukawa et al., 1998). The lamin B binding domain is also present in the LAP2() and£ 
isoforms but is partially absent in LAP2y and £, suggesting that the LAP2<i and £ isoforms 
may bind lamin B1 (Furukawa et al., 1995; Furukawa et al., 1998; Dechat et al., 2000b). 
However, it has also been shown that XLAP2~ exists in a protein complex with both A 
and B-type lamins in Xenopus, though this has yet to be shown for human LAP2~ (Lang 
and Krohne, 2003). 
LAP2~ has been suggested to be important for correct chromatin-NE interactions post-
mitosis as a basic domain within LAP2~ initiates DNA docking (Yang et al., 1997; Gant 
et al., 1999; Lang et al., 1999; Ulbert et al., 2006). Consistent with this, LAP2~ also 
contains an LEM domain that mediates the interaction an indirect interaction with DNA 
via the cross linking protein BAF, which binds DNA in a non-sequence-specific manner 
(Zheng et a/., 2000; Cai et a!., 2001; Shumaker et a!., 2001; Bradley et a!., 2005; Margalit 
et al., 2007). Furthermore, there is an additional LEM-like domain at theN-terminal of 
LAP2 proteins that interacts directly with DNA and LAP2~ can bind the chromatin 
protein HA95 via its C-terminal region (Cai et al., 2001; Martins et al., 2003; Ulbert et al., 
2006). This data suggests that LAP2~ is involved in gene expression by regulating higher 
order chromatin structures and, moreover, that this may be of a repressive nature as 
LAP2~ binds the transcriptional repressor GCL and also histone deacetylase (HDAC), 
which has been linked to transcriptionally inactive heterochromatin (Sadoni et a!., 1999; 
Nili et al., 2001; Somech et al., 2005). That LAP2~ binds to GCL implies that LAP2-
lamin complexes have a role in transcriptional control, as GCL is known to inhibit the 
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DP3 subunit of the E2F-DP3 complex independently ofRb (Nili et al., 2001; Gruenbaum 
et al., 2005; Broers et al., 2006). 
Another LAP2 family protein LAP2a also suggests that this protein family is involved in 
chromatin structure and transcriptional regulation (Cohen et al., 2001). Although LAP2a 
lacks a TM domain it may still reside at the nucleoplasmic face of the INM, held there by 
interactions with lamin B1 at the nuclear periphery (Foisner and Gerace, 1993; Dechat et 
a/., 1998). However, LAP2a also resides in the internal nucleoskeleton, where it 
preferentially binds and forms stable complexes with intranuclear A-type lamins during 
interphase, whilst it is located to telomeric chromosome regions in a phosphorylation 
dependent manner during mitosis along with LAP2~, BAF and emerin (Dechat et al., 
1998; Vlcek et al., 1999; Dechat eta/., 2000a; Markiewicz et al., 2002b; Vlcek eta/., 
2002; Dechat et a/., 2004; Margalit et a/., 2007). As with other LAP2 family members, 
LAP2a contains a LEM and anN-terminal LEM-like domain, mediating interactions with 
DNA indirectly (via BAF) and directly, respectively (Dechat et a/., 2000b). This data, 
together with FRAP (fluorescence recovery after photobleaching) studies showing that 
LAP2a and BAF are very mobile during interphase, suggests that lamin A/C-LAP2a-BAF 
complexes are involved in a dynamic ordering of chromatin during both mitosis and 
. interphase (Moir et a/., 2000; Sengura-Totten and Wilson, 2004; Vlcek et al., 2001; 
Dechat eta/., 2004; Shimi et al., 2004; Margalit eta/., 2007; Vlcek and Foisner, 2007a,b). 
Further evidence for the role LAP2 proteins in transcriptional regulation comes from the 
findings that lamin A-LAP2a complexes interact with the tumour suppressor 
retinoblastoma (Rb) (Mancini et a/., 1994; Ozaki et a/., 1994; Dechat et a/., 2000; 
Markiewicz eta/., 2002b). Lamin A-LAP2a acts to tether hypophosphorylated Rb to the 
nucleoskeleton where it binds to E2F-DP heterodimers and blocks E2F-dependent gene 
transcription via a variety of methods including the recruitment of SWI/SNF chromatin 
remodeling complex, HDAC, polycomb group protein complexes, and histone and DNA 
methyltransferases (Markiewicz eta/., 2002b; Chau and Wang, 2003; Stevaux and Dyson, 
2002 Frolov and Dyson, 2004; Korenjak and Brehm, 2005; Domer et al., 2006; Galderisi 
eta/., 2006). During G1, Rb is phosphorylated by cyclin D-CDK heterodimers allowing 
>- · progression to· S phase of-,the cell cycle, thereby making Rb an important regulator of 
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proliferation, and it has also been implicated in various differentiation processes (Chen et 
al., 1996; Novitch et al., 1999; Classon et al., 2000; Thomas et al., 1999; Fajas et al., 
2002; Cole et al., 2004; Hansen et al., 2004; Huh et al., 2004; Markiewicz et al., 2005; 
Domer et al., 2006). The LAP2a. C-terminal binds to the pocket C domain of Rb and can 
inhibit E2F-genes by directly binding to them in an Rb-dependent manner (Domer et al., 
2006). Overexpression of LAP2a. inhibits cell cycle progression and favors cell cycle exit 
and differentiation, a process that appears to be regulated upstream by the LAP2a. -
binding protein LINT-25 (Domer et al., 2006; Naetar et al., 2007). Also, a functional 
lamin A-LAP2a.-Rb complex is required to maintain a proliferative state within 
fibroblasts, with knockdown of either lamin A or LAP2a. leading to faster progression 
through G1 and S phase inducing cell cycle arrest (Pekovic et al., 2007). Consistent with 
this, LMNA-null MEFs show enhanced cell cycle arrest in response to DNA damage and 
mislocalisation of Rb with its subsequent proteasomal degradation (Johnson et al., 2004). 
Moreover, cell lines depleted of functionallamin A/C are resistant to p 16INK4A -mediated 
G1 arrest, reflecting the need for a functionallamin A-LAP2a.-Rb complex for effective 
cell cycle control (Nitta et al., 2006). Based on these· findings, the cell cycle and 
differentiation consequences of this lamin A-LAP2a.-Rb complex have been implicated in 
the control of adult stem cell self-renewal and differentiation (Hutchison and Worman, 
2004; Gotzmann arid Foisner, 2005). Mutations within the C-terminus of LAP2a. cause a 
rare form of dilated cardiomyopathy by affecting its interaction with lamin A/C (CMD1T; 
OMIM 188380) (Taylor et al., 2005). 
MANJ 
MANl is encoded by the human gene LEMD3 and is a 97 kDa protein implicated in 
transforming growth factor ~/bone morphogenic protein (TGF~/BMP) signalling (Lin et 
al., 2000; Lin et al., 2005; Pan et al., 2005; Worman, 2005; Worman, 2006; Bengtsson, 
2007; Wagner and Krohne, 2007). It was first identified as the largest (97 kDa) of three 
autoantigens recognized by autoantibodies from a human subject with collagen vascular 
disease (Paulin:-Levasseur et al., 1996; Lin et al., 2000). Structurally, MAN1 consists o[fi 
.- - ,_- .-- • -· ··'-. 'lS-•• '-c·r·l'tl·- " ·· - ••· ·.• ··· ·• >.• _.,_.,_v, · : •'··~ · · '· 
nucleoplasmic N-terminal domain, two transmembrane segments and a nucleoplasmic C-
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terminal domain (Lin et al., 2000). Deletion mutants and FRAP studies have shown that 
MAN1 localises to the INM via the 'selective retention model' and its INM position is 
dependent on theN-terminal TM and nucleoplasmic domains (Wu et al., 2002). TheN-
terminus has a conserved LEM-domain and interacts with emeri.n, GCL, Btf and BAF in 
vitro, as well as both A and B-type lamins via their tail domains (Lin et al., 2000; Liu et 
al., 2003; Mansharamani and Wilson, 2005). Several lines of evidence from various 
organisms have started to reveal the function of this protein. In C.elegans, Ce-MAN1 is 
essential for viability and normal chromosome segregation and is dependent upon a direct 
interaction with Ce-lamin for localisation to the INM (Liu et al., 2003). Whilst RNAi of 
Ce-MAN1 only resulted in 15% embryonic lethality, removal of Ce-emerin as well as Ce-
MAN1 led to 100% lethality, indicating that these two proteins share a degree of 
overlapping functionality (Liu et al., 2003). In Xenopus laevis, introduction of an 
antisense morpholino oligonucleotide to disrupt endogenous XMAN 1 leads to 
developmental complications (Osada et al., 2003). In humans, mutations in MAN1lead to 
three autosomal-dominant skeletal diseases: osteopoikilosis, Buschke-Ollendorff 
syndrome and melorheostosis, which are characterized by increased bone density (OMIM 
166700) (Hellemans et al., 2004; Hellemans et al., 2006). These diseases may be 
explained by the finding that the C-terminal globular nucleoplasmic domain adopts a 
winged-helix fold involved in receptor-regulated SMAD (rSMAD) binding and 
antagonizes TGF~/BMP signaling (Osada et al., 2003; Raju et al., 2003; Hellemans et al., 
2004; Lin et al., 2005; Pan et al., 2005; Caputo et al., 2006). Through this C-terminal 
motif, MANl associates with rSMADS 1-3, in particular SMADs 2 and 3, but not 
SMAD4, in a ligand-independent manner. Overexpression of MANl inhibits SMAD2/3 
phosphorylation, heterodimerization with SMAD4, thereby possibly sequestering them at 
the NE and thus causing repression of transcriptional activation of the TGF-~/BMP­
responsive promoters (Osada et al., 2005; Lin et al., 2005; Pan et al., 2005). Furthermore, 
MAN1 may possibly bind to both rSMADS and their targeted DNA sequences using the 
winged-helix fold motif and therefore directly influence gene expression (Caputo et al., 
2006; Worman, 2006). The exact mechanisms ofTGF-~/BMP antagonisation remain to be 
elucidated, but it has been recently suggested that MANl may function to either disrupt R-
> SMAD-co-SMAD complexes and/or induce-dephosphorylation of R-SMADs (Bengtsson, 
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2007). Regardless of the mechanism, the pathogenesis of the diseases associated with 
MANl mutations may be explained by the increased TGF-WBMP-signalling after 
regulation of rSMADs is abolished by the mutations (Worman, 2005). It has also been 
shown that TGF-WBMP singalling activates protein phosphatase 2A (PP2A), which in 
turn dephosphorylates rSMADs. Furthermore, PP2A dephosphorylates pRb in a cell-
cycle-dependent manner, with functional A-type lamins required for this 
dephosphorylation event (Van Berlo et al., 2005). In LMNA-null MEFs PP2A is unable to 
effectively dephosphorylate rSMADs, therefore allowing the perpetuation of the TGF-~ 
signal by activating collagen I and III promoters (Van Berlo et a/., 2005). 
Recently, a MAN1-like protein has been identified called LEM2 (orNET-25) (Schirmer et 
a/., 2003; Lee and Wilson, 2004). LEM2 contains a LEM-domain at its N-terminal, but 
lacks the specific C-terminal DNA-binding region of MAN1, necessary for TGF-WBMP-
signalling (Brachner et a/., 2006). It is a ubiquitously expressed 56 kDa protein localised 
to the INM, is dependent on a C-terminal interaction with A-type lamins for retention and 
behaves similarly to other LEM-domain containing proteins during mitosis (Haraguchi et 
al., 2001; Dechat et al., 2004; Brachner et al., 2006). Depletion of functional LEM2 by 
RNAi leads to nuclear abnormalities with these defects occurring independently of 
postmitotic NE reassembly, suggesting that LEM2 has a critical role in maintaining 
nuclear envelope integrity, possibly by interactions with proteins and/or chromatin on the 
nucleoplasmic side (Ulbert eta/., 2006). 
SUN proteins 
Mammalian cells contain at least four SUN domain containing proteins which share C-
terminal homology with three C.elegans proteins, UNC-83, UNC-84 and the germ-line 
specific Matefm (for role at the ONM, see page 12) (Malone eta/., 1999; Fridkin et al., 
2004; Hodzic et al., 2004; McGee et al., 2006). Mammalian SUN1 and SUN2 have been 
shown to localise to the INM with their C-terminal SUN domain extending into the PNS 
(Hodzic et al., 2004; Padamukmar et al., 2005). Evidence suggests that SUNl and SUN2 
may form both homodimers and heterodimers (Crisp et al., 2006; Wang et al., 2006). 
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Whilst in C.elegans, INM localisation of UNC-84 is dependent on its N-terminal 
interaction with Ce-lamin, SUNl and SUN2 are not dependent on the interaction with 
lamins for their retention at the INM, although they may bind to A-type lamins (Lee et a!., 
2002; Crisp et al., 2006; Haque et al., 2006; Hasan et al., 2006; Wang et al., 2006). 
Indeed, reintroduction of A-type lamins into LMNA-null MEFs does not lead to the correct 
localisation of SUN2, which is mislocalised in these cells and thus interactions, possibly 
with chromatin, have been suggested for SUNl and 2 retention (Crisp et al., 2006). 
However, interestingly, SUNl has been found to have a high binding affinity for prelamin 
A and due to the short-half of prelamin A, it has been suggested that SUNl may have a 
role in the incorporation of prelamin A into the nuclear lamina rather than prelamin A 
functioning to locate SUNl to the INM (Crisp et al., 2006). SUN3 is a testis-specific 
isoform that conforms to the general topology of SUNl and 2 (Crisp et al., 2006). 
Functionally, it has recently been shown that SUNl specifically associates with telomeres 
during meiotic prophase I and that overexpression of SUNl mutants leads to a failure of 
mammalian gametogenesis (Ding et al., 2007). This result was also conformed in an 
independent study of SUN2, suggesting a conserved mechanism of telomere attachment 
during meiosis (Schmitt et al., 2007). Recent evidence also implicates SUNl, but not 
SUN2, in helping to organize and distribute NPCs across the nuclear surface (Liu et al., 
2007). More widely reported has been the association of SUNl and SUN2 with nesprin-2 
in the PNS between their SUN domains and KASH domains respectively, forming a 
physical connection between the actin and microtubule cytoskeletons and the nucleus 
(Padamakumar et al., 2004; Crisp et al., 2006). Furthermore, it has been proposed that the 
SUN-nesprin link and subsequent ability to allow correct nuclear anchorage and migration 
may be mediated by the strength of the interaction between the two in the PNS via a 
pocket domain formed by the linker domain between the TM and the SUN domain 
(McGee et al., 2006). 
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Cytoplasm 
Nucl us 
Figure 2. Schematic diagram of interactions at the nuclear envelope. The nucleo-
cytoskeletal link is via the LINC complex. INM proteins interact with the underlying 
nuclear lamina. LEM-domain containing proteins all interact with BAF and thus interact 
indirectly with DNA. Lamin A/C is also found within the nucleoplasm where it is 
involved in a complex with a LAP2 isoform LAP2a and the hypophosphorylated form of 
Rb. (Adapted from Broers eta!. , 2006) 
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Structure, Function and Dynamics of the Nuclear Lamina 
Lamin structure and regulation of expression 
The nuclear lamina is a fibrous structure composed of lamin polypeptides underlying the 
INM and largely determines the overall structure of the nucleus during interphase 
(Fawcett, 1966; Burke and Stewart, 2002). The lamins are classified as either A or B-type 
depending on their protein structure, behavior during mitosis, biochemical properties, and 
their tissue expression specificity (Dwyer and Blobel, 1976; Gerace and Blobel 1980; 
Krohne and Benavente 1986; Broers et al., 1997; Broers et al., 2006; Mattout et al., 2006). 
Lamins are type V intermediate filaments (IFs) and as such they share a comparative 
tripartite domain structure, yet are distinct due to the presence of a NLS (Figure 3) 
(Hutchison and Worman, 2004; Smith et al., 2005; Mattout et al., 2006). Structurally, 
lamins consists of globular head and tail domains that border the central a-helical rod 
domain, which is divided into four coiled-coil domains (1A, 1B, 2A, and 2B), separated 
by flexible linker regions, and characterised by the presence of heptad repeats and an 
additional 42 amino acids (Hutchison and Worman, 2004). Lamins are targeted to the 
nucleus by the presence of a NLS in the tail domain that interacts with importins and 
permits nuclear import (Loewinger and McKeon, 1988; Monteiro et a!. 1994). 
Additionally, with the exception of lamin C, there is a CAAX motif at the C-terminal 
domain that is involved processing of the prepeptide to the propeptide (see page 32) 
(Sinensky et a!., 1994; Rusinol and Sinensky, 2006). Furthermore, lamins also contain an 
S-type immunoglobulin fold in their C-terminal (Dhe-Paganon et al., 2002; Krimm et al., 
2002). 
The assumed formation of lamin polymers is based largely on understanding from the 
formation of cytoplasmic IFs. However, lamins polymerize by forming obligate parallel 
homodimers of 50nm that interact via the coiled-coil domain and are then assumed to 
assemble into longer chains or filaments via head-to-tail interactions that then associate 
;J.~ laterally to form a higher order network (Sasse et al., 199?; Strelkov et al., 2004; 
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Herrmann and Aebi, 2004; Hutchison and Worman, 2004). Although all of the different 
mammalian lamin proteins interact in a yeast two-hybrid assay and in vitro biochemical 
assays, it remains to be elucidated whether the complex nuclear lamina of mammalian 
somatic cells contains heteropolymers or only homopolymers of lamins that form 
filaments in vivo (Gieffers and Krohne, 1991; Moir et al., 1991; Heitlinger et al., 1992; Ye 
and Worman, 1995; Schirmer and Gerace, 2001; Schirmer and Gerace, 2004). However, a 
recent study using quantitative FRET (fluorescence energy resonance transfer) analysis 
has suggested lamins may exist as homopolymers with subsequent interactions between 
both A and B-type lamin homopolymers (Delbarre et al., 2006). 
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Figure 3. General structure of lamin polypeptides. (See text for details, adapted from 
Hutchison and Worman, 2004) 
Humans have three distinct genes that encode seven different lamin polypeptides 
(Hutchison and Worman, 2004). A-type lamins arise by alternative splicing of RNA 
encoded by LMNA, a 12 exon gene which is localised to chromosome 1q21.2 (Fisher et 
al., 1986; Lin and Worman, 1993; Wynder et al., 1996). There are four known splice 
isoforms of LMNA, lamin A, lamin C, lam in A/11 0 and lam in C2 (Fisher et a/., 1986; Lin 
and Worman, 1993; Furukawa et al., 1994; Alsheimer and Benavente, 1996; Machiels et 
al., 1996). Lamins A and C are identical for their first 566 amino acids but vary in their C-
terminal, with lamin C containing five unique C-terminal amino acids and 1amin A an 
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additional 98 amino acids (Burke and Stewart, 2006). Lamin MlO is an isoform lacking 
the amino acids encoded by ex on 10, whilst lamin C2 is a male germline-specific isoform 
arising from alternative splicing of mRNA initiated from a different start site (Furukawa et 
al., 1994; Alsheimer and Benavente, 1996; Machiels et al., 1996). Two unlinked genes 
encode three separate B-type lamins. Lamin B1 is encoded by LMNBJ and is located on 
chromosome 5q23.3-q31.1 (Lin and Worman, 1995; Wydner et al., 1996). Whilst 
LMNB2, located on chromosome 19p13.3, encodes two alternatively spliced isoforms, 
lamin B2 and lamin B3 (Hoger et al., 1990; Biamonti et al., 1992; Furukawa and Horta, 
1993). 
Both A and B-type lamins are developmentally regulated (Broers et a/., 2006). B-type 
lamins are ubiquitously expressed in all cell types with lamins B 1 and B2 required for cell 
survival in both embryos and adult tissues as well as for maintenance of nuclear shape and 
development (Lehner et al., 1987; Harborth et al., 2001; Steen and Collas, 2001; Vergnes 
et al., 2004). Lamin B3 is a male germline-specfic lamin B2 splice isoform, conferring 
some characteristics to the shape of the gamete nuclei, suggesting that lamins have tissue-
specific effects (Furukawa and Horta 1993; Furukawa et al., 1994). 
In contrast, A-type lamins have been implicated in differentiated cells types with a pattern 
of expression primarily driven by the developmental program controlling embryogenesis 
and organ differentiation (Rober et al., 1989; Holaska et al., 2002). Essentially, although 
there are some discrepancies amongst the reported data, early embryo and embryonic stem 
cells do not express A-type lamins but are usually induced during development after cells 
have committed to a differentiation pathway (Schatten et al. 1985; Stewart and Burke 
1987; Houliston et al. 1988; Rober et al. 1989; Pugh et al., 1997; Gruenbaum et al. 2003; 
Constantinescu et al. 2006). Further to this, LMNA-null mice progress quite normally 
during early stages of development but then display severely retarded postnatal growth 
characterised by the appearance of muscular dystrophy and cardiomyopathy, suggesting 
A-type lamins are not essential for development (Sullivan et al., 1999). However, in 
humans, haploinsufficiency for LMNA, due to the presence of a nonsense mutation at 
codon 6, or the presence of a homozygous" mutation leading to a premature stop codon in 
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LMNA causes postnatal death or death in utero (Bonne et al., 1999; van Engelen et al., 
2005). 
Lamins A and Care the major two gene products of LMNA, with lamin MlO expressed in 
tumour cell lines as well as several normal cell types (Machiels et al., 1996). The minor 
LMNA splice variant, lamin C2, is specific to male gametes and is the only A-type lamin 
detected there (Furukawa et al., 1994; Alsheimer and Benavente 1996). Tissue levels of 
lamin A and C are dependent on the differentiation state of the tissue, whilst ratios of 
laminA to C may also differ amongst tissues (Worman et al. 1988; Lanoix et al. 1992; 
Martelli et al. 1992; Hamid et al. 1996, Broers et al., 1997; Lattanzi et al. 2003, 
Constantinescu et al. 2006). Thus, that A-type lamins are expressed most highly amongst 
differentiated cells has led to the hypothesis that A-type lamins maintain a differentiated 
cell state, although they do not directly influence differentiation (Stewart and Burke 1987; 
Rober et al. 1989, Peter and Nigg, 1991; Pugh et al., 1997; Constantinescu et al. 2006). 
As well as embryonic stem cells, notable exceptions where cells do not express A-type 
lamins or do so at lower levels include some immune system stem cells, some 
hematopoietic stem cells, some neuroendocrine system cells and some forms of cancer 
where it is associated with cancer subtypes and aggressiveness (Guilly et al., 1987; Lebel 
et al., 1987; Paulin-Levasseur et al. 1988, Worman et al., 1988; Rober eta/. 1989; Rober 
eta/. 1990, Stadelmann eta/. 1990; Broers eta/. 1993; Machiels et al. 1997; Moss eta/. 
1999; Venables eta/. 2001; Mounkes et al. 2003; Tilli et al., 2003; Agrelo eta/. 2005; 
Coradeghini et al., 2006). 
A-type lamins are presumed to be primarily regulated at the level of transcription (Mattia 
et a/. 1992, Alsheimer and Benavente 1996, Hamid et a/. 1996; Pugh et a/., 1997); 
however, evidence suggesting a role for post-transcriptional regulation also exists (Lanoix 
et al. 1992). The proximal promoter of rat LMNA has been characterised, with various 
motifs important in determining the overall activity of the lamin A/C promoter 
(Muralikrishna and Parnaik 2001; Janaki Ramaiah and Pamaik, 2006). The GC box at-
' 101 has the ability to bind Spl/Sp3 transcription factors, and the AP-1 motif at -7 is able 
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to bind c-Jun and c-Fos (Nakajima and Abe 1995; Tiwari et al. 1998; Muralikrishna et al., 
2001). Moreover, there is a GT-rich motif at -55 that binds to the Sp family of 
transcription factors and has been shown to interact with the transcriptional coactivator 
CREB-binding protein (CBP) via ChiP (chromatin immunoprecipitation) analysis (Janaki 
Ramaiah and Parnaik, 2006). Furthermore, a 420 base pair regulatory region was 
identified within intron 1 of rat LMNA, with a suggested function to control that it may 
control cell-type-specific transcription of A-type lamins (Arora et al. 2004). A retinoic 
acid responsive element within the lamin A/C promoter (termed L-RARE) has also been 
identified in P19 embryonic carcinoma (EC) cells between position -54 and -36 that 
promotes lamin A/C transcription upon retinoic acid treatment (Okumura et al., 2000; 
Okumura et al., 2004). The study of lamin A/C transcription has proved important as 
silencing of lamin A/C expression has been correlated with hypermethylation of promoter 
CpG islands in human leukaemia and lymphoma cells and provides a mechanistic 
epigenetic basis for some malignancies (Agrelo et al. 2005). 
Processing of prelamin A 
Lamin A is synthesised as a precursor prelamin A molecule before insertion into the 
nuclear lamina (Gerace et al., 1986; Dagenais et al., 1985; Lehner et al., 1986; Becket al., 
1990). Proteins that undergo lipid modification, called protein prenylation, can be drawn 
into two groups depending on their lipid modification (Young et a!., 2005). One group 
consists of Rab GTPases that are geranylgeranylated at terminal cysteine residues (Young 
et al., 2005). The other is a group of proteins (prelamin A, lamin B 1, lamin B2, Ras, Rho) 
that contain a CAAX motif (C = cysteine, A = any aliphatic amino acid, X = S, M, C, A, 
Q, L) at the C-terminal (Sinensky et al., 1994). Where X is S, M, C, A or Q then the 
protein is first farnesylated ( 15-carbon lipid), whereas if X is L then it is 
geranylgeranylated (20-carbon lipid) (Seabra et a!., 1992; Armstrong et a!., 1995). These 
proteins are then further modified, first by an endoproteolytic processing event and then 
by methylation of the C-terminal prenylcysteine (Clarke, 1992; Zhang and Casey, 1996; 
Young et al., 2005). Prelamin A is unique to this group as it undergoes an additional 
endoproteolytic step that removes the last 15 amino acids, including the famesylcysteine 
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methyl ester, from the C-terminal to produce mature lamin A (Figure 4) (Beck et a/., 
1990; Lutz eta/., 1992). 
Wild type 
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Famasylatlon (FTasel ~ ~ 
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c-termtnal cleavage 
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and Reel) t ~ 
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Upstream cleavage I (Zmps~ r Upstream cleavage 
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Hutchinson-Gilford 
Progeria Syndrome R644C 
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CAAX CAAX 
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• 
~ Methylation (lcmt) ~ Pretomin A(57 kDa)-.Pmgorin C-octt, Prelamln A 174 kDa) 
Figure 4. Processing pathway of wild type prelamin A and in disease. Wild type prelamin 
A undergoes a series of post-translational processing steps before mature lamin A is 
formed. Prelamin A transcripts in HGPS contain an internal deletion of 50 amino acids 
which removes the second endoproteolytic cleavage site, resulting in prelamin A that is 
both famesylated and carboxymethylated, with the mutant product termed progerin. In an 
atypical form of HGPS, arginine is mutated to cysteine at position 644, resulting in an 
alteration to the Zmpste24 recognition site required for the last processing step. Again, the 
mutant prelamin A is expected to be both famesylated and carboxymethylated. Although 
not shown here, in Zmpste24_1_ cells there is in an accumulation of a prelamin A transcript 
that is found in cells that harbor the lamin A R644C mutation, with the earlier proteolytic 
step carried out by Reel. (Adapted from Young eta/., 2005) 
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The first step of prelamin processing is the farnesylation by protein farnesyl transferase 
and involves the addition of a 15-carbon farnesyl lipid via a thioester linkage to the thiol 
group of the cysteine within the CAAX motif (Sinensky et al., 1994). Lamin famesylation 
assists in targeting the proteins to the nuclear envelope (Holtz et al., 1989; Kitten and 
Nigg, 1991). Evidence suggests that farnesylation is an absolute requirement for the 
assembly of lamin A into the nuclear lamina as cells incubated with the isoprenoid 
biosynthesis inhibitor, lovastatin, causes nonfarnesylated prelamin A to accumulate into 
nucleoplasmic aggregates (Holtz et al., 1989; Becket al., 1990; Lutz et al. 1992). It has 
been suggested that farnesylation occurs at distinct nucleoplasmic foci (Lutz et al. 1992, 
Moir et al. 1995). Supporting this, NARF (nuclear prelamin A recognition factor) is a 
nuclear membrane associated protein also found at nucleoplasmic foci that binds the C-
terminal tail of prelamin A with prenylation dependent specificity, and although its 
function is unknown, it may be involved in properly presenting the substrate to the active 
site of Zmpste24 (Barton and Worman 1999). Recent studies have shown that when a 
prelamin A mutant (L647R), which cannot undergo its fmally endoproteolytic step 
cleavage step, was co-transfected with a SUNl N-terminal domain construct into LMNA-
null MEFs, the SUNl N-terminal construct was relocalised away from the nucleoplasm to 
the NE, revealing a strong interaction between farnesylated carboxymethylated prelamin 
A and theN-terminal of SUNl (Crisp et al., 2006). The authors have suggested that rather 
than targeting SUNl to the NE, SUNI may function to target prelamin A to the NE for 
incorporation into the nuclear lamina (Crisp et al., 2006). However, these hypotheses, for 
both NARF and SUNland their relationship to prelamin A, require further work. 
After famesylation, the last three peptides of the protein (the -AAX of the CAAX motif) 
are cleaved either by the endoproteinase Zmpste24 (alternatively called FACEt but herein 
referred to solely as Zmpste24), a multi-spanning membrane zinc metalloproteinase 
localized to the endoplasmic reticulum and nucl~ar envelope, or Reel (Ras-converting 
enzyme 1) (Bergo et al. 2002, Pendas et al. 2002; Corrigan et al., 2005). The newly 
exposed farnesylcysteine is methylated by isoprenylcysteine carboxy methyltransferase 
(ICMT; also a membrane protein in the ER and nucleus) (Sinensky et al., 1994). The 
>~ presence of this famesylated and carboxymethylated peptide acts to block the 
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polymerisation of lamin A into the nuclear lamina, although these steps are fundamental 
for processing of prelamin A to lamin A (Lutz et a/., 1992; Kilic et a/., 1997). 
Finally, the last fifteen amino acids of prelamin A are then endoproteolytically removed 
by Zmpste24, which recognises the conserved hexapeptide RSY !LLG, producing mature 
lamin A which then integrates into the nuclear lamina (Weber et a/., 1989; Lutz et a!., 
1990; Kilic eta/., 1997; Corrigan eta/., 2005). Although Zmpste24 is responsible for the 
cleavage of -AAX and the later cleavage of the terminal 15 amino acids in insect cells, it 
is not known whether this is true for mammalian cells (Bergo eta/. 2002; Corrigan eta!., 
2005). However, overexpression of a Zmpste24 expression plasmid is sufficient to restore 
the prelamin A processing in Zmpste24_,_ MEFs and produce mature laminA, suggesting a 
role for both cleavage events (Pendas eta!. 2002). 
A functional CAAX motif seems to be essential for prelamin A incorporation into the 
nuclear lamina, with each modification highly specific and dependent on the previous 
modification (Hennekes and Nigg, 1994; Monteiro et a/., 1994; Izumi et a!., 2000; 
Corrigan et a/., 2005; Rusinol and Sinensky, 2006). It has been suggested that the 
multitude of steps involved in the processing of prelamin to mature lamin A confers the 
ability to reversibly associate with membranes via a hydrophobic interaction with the 
phospholipid bilayer (Dalton and Sinensky, 1995; Rando, 1996; Kilic et a!., 1999; 
Corrigan et a!., 2005). Alternatively, the processing may aid in the interaction with a 
membrane receptor protein, such as the interaction between famesylated lamin B with its 
INM anchor LBR or the interaction between NARF/SUN1 and famesylated (and 
carboxymethylated for SUN1) prelamin (Marshall 1993; Ye and Worman 1994; Kisselev 
et al., 1995; Kilic eta!., 1997; Barton and Worman 1999; Lin eta!., 2000; Crisp eta!., 
2006). 
However, the processing steps of prelamin A are not required for the incorporation of 
laminA into the nuclear lamina, as microinject~d laminA is incorporated into the nuclear 
lamina (Pugh et a!., 1997; Goldman et a!., 2004). Furthermore, mature lamin A is 
- disassembled~andreassembledcinta-the·lamina-during the course-ofmitosis(Gerace et-a!., - - -~~ 
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1984). Indeed, it has been shown that A-type lamins are transiently localized to the 
nuclear interior during G 1 and become incorporated into the lamina as G 1 progresses 
(Bridger et al. 1993, Dechat et al. 2000a, Moir et al. 2000; Holaska et al. 2002). LaminA 
also forms a nucleoplasmic veil during interphase although the nature of remains to be 
fully clarified (Rozak et al., 1995; Broers et al., 1999; Zastrow et al., 2004). Whilst lamin 
A contains a CAAX motif and endoproteolytic site, lamin C does not and thus A-type 
lamins follow different pathways of incorporation into the lamina (Broers et al., 2006). 
Although both proteins are usually incorporated in the nuclear lamina in roughly 
equivalent amounts, it has been reported that lamin C is dependent on lamin A for 
localization to the NE as well as for incorporation into the lamina (Pugh et a!. 1997, 
Vaughan et al. 2001). Microinjected lamin C accumulates as nucleoplasmic foci before 
integration into the peripheral lamina (Pugh et al. 1997). Moreover, the presence of lamin 
C can cause lamin A to default to the lamin C pathway and become incorporated into 
intranuclear foci before transit to the peripheral lamina (Pugh et al. 1997). Similarly, 
microinjected lamin A is initially localized to the nucleoplasm before incorporation in the 
peripheral lamina (Goldman et al. 1992, Schmidt et al. 1994). Whilst mature laminA may 
incorporate into the nuclear lamina it is clear that the evolutionary conserved prelamin A 
processing has a crucial, if not yet fully known, functional significance. 
Lamina function 
The functions of lamins have largely been based on their various interactions in the 
nucleus (Zastrow et al., 2004). These functions can be broadly classified into the 
following groups: tensegrity element; chromatin scaffold; transcriptional partner; genomic 
caretaker (Hutchison and Worman, 2004; Zastrow et al., 2004; Smith et al., 2005; 
Verstraten et al., 2007; Vlcek and Foisner, 2007b). 
Several lines of evidence suggest that the lamina is essential in maintaining the structure 
of the nuclear envelope, by virtue of their ability to resist deformation and protect 
_ch!-o._lll__atin and as su~~h~~~, b~n~ ci_e_~cri~ed as a te~~~gtitv. _ el~ment (ll1.1Khi~o_n_ and 
Worman, 2004). Knockout mouse lines for both LMNA and LMNBJ have yielded 
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important results underlining their structural importance. Lamin B 1 and B2 are 
ubiquitously expressed in nearly all cells and mice homozygous for LMNBJ die at birth 
whilst fibroblasts exhibit gross nuclear envelope defects (Vergnes eta/., 2004). Mice null 
for LMNA have decreased mechanical properties, leading to nuclear envelope defects and 
mislocalisation ofiNM proteins (Sullivan eta/., 1999; Harborth eta!., 2001; Muchir eta/., 
2003; Broers eta/., 2004; Lammerding eta/., 2004; Nikolova eta/., 2004). Furthermore, 
cells in which disease-causing lamin A/C mutants are transiently overexpressed display 
increased nuclear defects (Ostlund eta!., 2001; Rahrujo eta/., 2001; Vigouroux eta!., 
2001; Novelli eta!., 2002; Capanni eta/., 2003; Chen eta/., 2003; Eriksson eta/., 2003; 
Favreau eta/., 2003; Holt eta/., 2003; Goldman eta/., 2004; Muchir eta/., 2004; Navarro 
eta/., 2004). Lamins have been directly implicated in nuclear size as overexpression of 
CAAX-motif-containing lamins leads to increased nuclear membrane growth (Ralle et a/., 
2004; Profert et a/., 2004). Moreover, another CAAX-motif-containing protein in 
Drosophila, Kugelkem, has been suggested to be a rate-determining factor for nuclear size 
increase (Brandt et a/., 2006). Lamins interact with the nucleoporin Nup153 and are 
responsible for positioning and anchoring the NPC as LMNA null cells show asymmetric 
NPC distribution (Sullivan et a!., 1999; Smythe et a/., 2000). Evidence of a nucleo-
cytoskeletal link suggests that lamins also have a role in maintaining cellular integrity via 
the LINC complex and that mutations in lamin A/C may cause muscular dystrophy serves 
to reinforce this (Bonne eta!., 1999; Mislow eta/., 2002a,b; Nikolova eta!., 2004; Libotte 
eta/., 2005; Zhang eta!., 2005; Houben et al., 2007). 
The suggestion that the lamina may act as a chromatin scaffold or anchor is based on 
evidence showing that lamins bind DNA, chromatin and core histones via the lamin A/C 
C-terminal domain (Luderus eta/., 1992; Glass et al., 1993; Luderus eta/., 1994; Taniura 
et a/., 1995). Furthermore, given this interaction it would allow lamins to serve as 
scaffolds for multiprotein complexes associated with chromatin (Stierle et al., 2003). 
Moreover, lamin A may also bind chromatin via BAF, which also mediates the non-
specific binding of LEM-domain containing proteins to chromatin (Zheng et a/., 2000; 
Lee et a/., 2001; Shumaker et al., 2001; Holaska et a/., 2003; Liu et a/., 2003). 
> Nucleoplasmico- A-type-lamins -have been suggested- to act· -as a scaffold for RNA-
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polymerase II-dependent transcription, DNA synthesis and RNA splicing, although the 
latter may function independently of a lamin scaffold (Meier et al., 1991; Spann et al., 
1997; Jagatheesan et al., 1999 Moir et al., 2000; Kumaran et al., 2002; Spann et al., 2002; 
Vecerova et al., 2004). 
Several transcriptional regulators have been found to interact with lamins such as MOK2 
and Oct-1, which interact with lamin A/C and B, respectively (Imai et al., 1997; Dreuillet 
et al., 2002; Zastrow et al., 2004). The expression of lamin A/C mutations in the MOK2 
binding domain casues the relocalisation of MOK2 into nuclear aggregates, which has 
been hypothesized to deregulate MOK2 target genes (Dreuillet et al., 2007). Another is 
Rb, and the lamin A/C-LAP2a-Rb complex functions to control cell cycle progression and 
differentiation, with loss of either lamin A/C or LAP2a causing abnormal cell cycle 
characteristics (See page 20) (Markiewicz et al., 2002b; Johnson et al., 2004; Dorner et 
al., 2006; Nitta et al., 2006; Pekovic et al., 2007). Furthermore, lamin A/C is thought to 
act as an essential docking site for the control of Rb dephosphorylation by PP2A, which 
also acts to dephosphorylate rSMADs in two independent pathways and thus LMNA-null 
MEFs show increased proliferation and increased fibrosis (See page 23) (Van Berlo et al., 
2005). Recently, it has been suggested that the interaction between lamin A/C and the 
transcription factor c-Fos acts to sequester it at the NE, which results in the AP-1 mediated 
gene transcription (lvorra et al., 2006). Subsequent release form this repressive complex 
allows the formation of C-Fos/C-Jun heterodimers (AP-1 complex) and activation of 
target genes (Ivorra et al., 2006). Prelamin A has been found to be a binding partner for 
the sterol regulatory element binding protein (SREBP 1 ), a member of the bHLH 
transcription factor family that upregulates PPARy during adipogenesis (Fajas et al., 1999; 
Lloyd et al., 2002; Capanni et al., 2005; Feve, 2005; Rosen, 2005). Due to the interactions 
of lamin A/C with emerin at the INM, lamin A/C has been indirectly implicated in signal 
transduction and transcription as ~merin has been shown to bind to ~-catenin, involved in 
the canonical Wnt pathway (Markiewicz et a!., 2006). 
Lamins have also been labeled 'genomic caretakers' as defective processing of prelamin A 
has been~linked·to increase&HNA damage-(Misteliand-Scaffidi, 2005;-Lees-Miller, 2006; 
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Liu et al., 2006; Manju eta!., 2006; Verstraten eta!., 2007). HOPS fibroblasts show an 
increased amount of unrepaired DNA as judged by the presence of foci containing 
phosphorylated histone H2AX (Scaffidi and Misteli, 2006). Furthermore, the recruitment 
of DNA repair factors 53BP and Rad51 to H2AX-tagged sites of DNA lesions is delayed 
in human HOPS fibroblasts as well as in Zmpste24-null MEFs, and with transient 
overexpression of expression plasmids reversing these effects it draws a direct link to 
prelamin A as being the primary cause (Liu et al., 2005). Additionally, H2AX-53BP 
complexes take longer to dissociate in Zmpste24-null MEFs, and these cells show 
increased sensitivity to DNA damaging agents with a resulting overall increase in levels of 
genomic instability (Liu et a!., 2005). Transcriptional analyses carried out on tissues from 
Zmpste24-null MEFs showed an upregulation of classical p53 target genes, which is 
involved in a pathway that induces cell and tissue senescence and eventually leads to 
accelerated aging (Campisi, 2005; Varela et a!., 2005). Lamin A/C is upregulated in a 
p53-dependent manner, suggesting that they may be linked and implicates p53 signaling 
in laminopathies (Rahman-Rohblick et al., 2007). Subsequently, the existence of a 
'structural cell cycle checkpoint' involved in the detection of nuclear envelope and/or 
chromatin abnormalities has been proposed (Cadinanos et al., 2005; Varela et al., 2005). 
Apart from DNA damage, mutations in lamins and alterations to prelamin A processing 
causes loss of heterochromatin and changes in epigenetic modifications that regulate 
heterochromatin (Sullivan et al., 1999; Goldman et al., 2004; Nikolova et al., 2004; 
Columbaro et al., 2005; Filesi et al., 2005; Scaffidi and Misteli, 2005; Maraldi et a!., 
2006a,b; Shumaker et al., 2006; Lattanzi et al., 2007; Maraldi et al., 2007a,b). 
Envelopathies 
Diseases that arise due to mutations within proteins at the nuclear envelope have been 
collectively termed envelopathies (Burke and Stewart, 2006). These include an autosomal 
recessive form of cerebellar ataxia (caused by mutation in nesprin 1 ), PHA and 
HEM/Greenberg skeletal dysplasia (LBR), X-linked EDMD (emerin), dilated 
cardiomyopathy_ (LAP2a), and three skeletaLdiseases: osteopoikilosis,- Buschke-
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Ollendorff syndrome and melorheostosis (all MANl) (Bione et al., 1994; Manilal eta/., 
1996; Nagano eta/., 1996; Hoffmann et al., 2002; Best et al., 2003; Waterham eta/., 
2003; Hellemans et al., 2004; Taylor et al., 2005; Hellemans et al., 2006; Gros-Louis et 
a/., 2007). A subset of nuclear envelopathies are those diseases caused by mutations in 
lamins, called laminopathies. 
Laminopathies 
Mutations in both A and B type lamins g1ve nse to a wide spectrum of diseases 
collectively called laminopathies and reviewed extensively within the literature reflecting 
a growing interest in these key nuclear proteins (Gruenbaum et a/., 2005; Smith et a/., 
2005; Worman and Courvalin, 2005; Broers et al., 2006; Burke and Stewart, 2006; 
Gotzmann and Foisner, 2006; Maraldi et al., 2006a,b; Mattout et al., 2006; Parnaik and 
Manju, 2006; Rankin and Ellard, 2006; Young et al., 2006; Verstraeten et al., 2007; 
Worman and Bonne; 2007). Primary laminopathies arise from mutations within LMNA, 
LMNBJ, or LMNB2 and disease-causing mutations within Zmpste24 are called secondary 
laminopathies. Whilst disease-causing mutations within A-type lamins were first 
identified in 1999, mutations within the two lamin B genes have only recently been 
discovered. Duplication of LMNBJ causes adult-onset AD leukodystrophy, characterised 
by progressive loss of myelin in the central nervous system (ADLD; OMIM 169500) 
(Padiath et a!., 2006). Barraquer-Simmons syndrome is a sporadic acquired partial 
lipodystrophy resulting from mutation within LMNB2 (APL; OMIM 608709) (Hegele et 
al., 2006). The mechanistic basis for how mutations in these two genes cause two very 
distinct diseases remains unknown. Indeed, that there are now more than 250 mutations 
that have been documented within LMNA and how mutations within a single protein 
ubiquitously expressed in differentiated tissues can cause varying disease phenotypes is an 
intriguing question (Hutchison et al., 2001; http://www.dmd.nl/lmna_home.html). Some 
have attempted to correlate laminopathy phenotypes with the genotype, however such is 
the homogeneity of mutations throughout gene that it proved impossible to predict a 
_definite genotype .. phenotype association~(Hegele, 2005). 
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Figure 5. Disease-causing lamin A/C mutations. Comprehensive diagram showing the 
positions of mutations in LMNA and the diseases they cause. (See text for details of each 
laminopathy, adapted from Burke and Stewart, 2006). 
Autosomal Dominant - Emery Dreifuss muscular dystrophy (AD-EDMD) 
Whilst X-linked EDMD is due to a mutation within the INM protein emerin, mutations 
within lamin A/C may cause an autosomal dominant form of EDMD (OMIM 181350) 
(Bione eta!. , 1994; Bonne eta!. , 1999; Muchir et a/., 2006). AD-EDMD presents during 
childhood and leads to progressive wasting of muscle, initially of the humeroperoneal and 
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then limb girdle muscles, and frequently these are cardiac defects, notably dilated 
cardiomyopathy (DCM) (Bonne eta/., 2000). Mutations are primarily nonsense mutations 
and their location throughout the gene underline the absence of a genotype-phenotype 
relationship (Bonne eta/., 2000; Helbling-Leclerc eta/., 2002; van der Kooi eta/., 2002; 
Muchir et al., 2004). Notably, there is also a rare autosomal recessive form of EDMD, 
which caused severe muscle wasting by 40 years of age (OMIM 604929) (Raffaele Di 
Barletta eta/., 2000). 
Dilated cardiomyopathy with conduction system defect (CMDJA) 
Dilated cardiomyopathy with conduction system defects is characterised by cardiac · 
dilation and reduced systolic function, with an atrioventricular conduction block or atrial 
arrhythmias, frequently resulting in sudden death (OMIM 115200) (Fatkin eta/., 1999; 
Brodsky et a/., 2000; Charniot et al., 2003; Sanna et al., 2003; Sebillon et a/., 2003; 
Hermida-Prieto eta/., 2004). However, there is little or no skeletal muscle involvement as 
is the case for AD-EDMD (Fatkin eta/., 1999). Most mutations found for DCM-CD1 are 
located in the rod domains oflamins A and C (Fatkin eta/., 1999; Broers eta/., 2006) 
Limb girdle muscular dystrophy JB (LGMD JB) 
The autosomal dominant limb girdle muscular dystrophy type 1B has a range of clinical 
features, but is essentially characterized by progressive limb girdle weakness and an 
associated DCM (OMIM 155001) (Muchir et a/., 2000; Emery, 2002). Again, most 
mutations in LMNA that cause LGMD 1B were found to be missense mutations with 
analysis showing that these three striated muscle disorders are allelic variants and that 
members of the same family with the same mutations may present different phenotypes 
(Bonne et a/., 2000; Brodsky et a!., 2000; Muchir et a/., 2000). 
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Charcot-Marie-Tooth syndrome type 2b (CMT2Bl) 
CMT2B 1 is an autosomal recessive axonal disease characterised by reduced motor nerve 
velocities with associated muscle wasting in the lower and upper limbs (OMIM 605588) 
(De Sandre-Giovannoli et al., 2002; Chaouch et al., 2003; Tazir et al., 2004). Mice null 
for LMNA also show a similar axonal phenotype to human patients homozygous for the 
R298C mutation found in CMT2B 1 (De Sandre-Giovannoli et al., 2002). 
Lipodystrophies 
Lipodystrophies are a heterogeneous group of disorders characterised by complete or 
partial loss of adipose tissue and is often associated with insulin-resistant diabetes mellitus 
(Kobberling and Dunnigan, 1986; Hegele, 2000; Reitman et al., 2000). One of these, 
Dunnigan-type familial partial lipodystrophy, is a rare disorder that presents at puberty 
and is characterised by progressive loss of subcutaneous ·adipose tissue from the 
extremities, trunk and gluteal region, with a concomitant accumulation of adipose tissue in 
the intra-abdominal region, face and neck (FLPD; OMIM 151660) (Garg et al., 1999; 
Hegele et al., 2000; Lelliott et al., 2002; Agarwal and Garg, 2006). Furthermore, the 
disorder is associated with metabolic complications, with a likelihood of glucose 
intolerance, insulin resistance and type II diabetes mellitus, which is more prevalent in 
women than men (Rankin and Ellard, 2006). Three groups mapped the FPLD gene to 
chromosome 1q21-22 (Jackson et al., 1998; Peters et al., 1998; Anderson et al., 1999), a 
region containing over 1 00 genes including the LMNA. A short time thereafter, LMNA was 
confirmed as the causative gene in FPLD (Cao and Hegele, 2000; Shackleton et al., 2000; 
Speckman et al., 2000). To date, the majority of mutations, some 75%, involve missense 
mutations of the arginine at codon 482 (R482Q, R482W, R482L), which is positioned 
within ex on 8 in the globular carboxy- terminal of both lamins A and C (Haque et a!., 
2003; Capeau et al., 2005; Agarwal and Garg, 2006; Burke and Stewart, 2006; Jacob and 
Garg, 2006). Other mutations occur at codon 486 and in exon 11 at codons 582 and 584, 
with _the latter. two presenting as . atypical cases -of . FLPD as-the patients- had mild 
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subcutaneous fat loss when compared to typical patients with a R482 mutation (Speckman 
et al., 2000; Vigoroux et a/., 2000; Garg et a/., 2001; Garg et a/., 2002). Patients with 
FLPD have also been found to have N-terminal mutations in lamin NC (R28W and 
R62G) with the patients suffering from both muscle weakness and cardiac dysfunction, 
which are notably absent from typical cases of FLPD (Garget a/., 2002; Jacob and Garg, 
2006). 
Werner's Syndrome (WRN) 
Typical Werner's syndrome is an autosomal recessive premature aging disease caused by 
mutations within RECQL2, a gene that encodes a RecQ DNA helicase, and is 
characterised by scleroderma-like skin changes, cataract formation, subcutaneous 
calcification, premature arteriosclerosis, diabetes mellitus, short stature and predisposition 
to cancer (WRN; OMIM 277700) (Goto et a/., 1997; Yu eta/., 1997; Mohaghegh and 
Hickson, 2001). Atypical Werner's syndrome is a more severe than typical WRN and is 
caused by missense mutations in LMNA, specifically within both the rod domain and C-
terminal globular domain (Chen et al., 2003; Hegele, 2003). 
Mandibuloacral dysplasia (MAD) 
Mandibuloacral dysplasia type A is characterised by post-natal growth retardation, skeletal 
abnormalities such as hypoplasia of the mandible and clavicles, short stature and partial 
lipodystrophy, and premature aging, thus sharing phenotypes of two other laminopathies, 
HGPS and FPLD (MADA; OMIM 248370) (Novelli eta/., 2002; Simha and Garg, 2002; 
Afifi and El-Bassyouni, 2005). MADA is caused by a homozygous R527H mutation 
(Novelli et al., 2002; Shen et al., 2003; Simha eta/., 2003). This mutation is located in the 
C-terminal globular domain of lamin A and leads to the accumulation of prelamin A at the 
nuclear envelope, the formation of intranuclear prelamin A-containing structures and a 
loss of heterochromatin markers (Filesi et al., 2005). Mandibuloacral dysplasia type B is 
similar to MADA but caused by mutations within Zmpste24, and is characterised by 
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generalised lipodystrophy affecting the extremities (OMIM 608612) (Agarwal et al., 
2003). 
Restrictive Dermopathy (RD) 
RD is an autosomal recessive fatal perinatal disorder characterised by severe intrauterine 
growth retardation, and tight skin with generalised contractures, resulting in death usually 
after a few days (OMIM 275210) (Navarro et al., 2004). The disease is caused by 
mutations in either LMNA due to complete loss of exon 11 and subsequent loss of the 
second endoproteolytic cleavage site, or in Zmpste24 due to the heterozygous insertion of 
1 bp causing a premature stop codon and therefore suppressing the protease activity of 
Zmpste24 (Navarro et al., 2004; Levy et al., 2005; Moulson et al., 2005; Toth et al., 
2005). 
Hutchinson-Gilford Progeria Syndrome (HGPS) 
Hutchinson-Gilford Progeria Syndrome (HGPS) is a severe laminopathy, with a reported 
incidence of 1 :4-8 million and since 1886 just over 100 cases have been reported with 40 
known current cases worldwide (OMIM 176670) (Novelli and D' Apice, 2003; Pollex and 
Hegele, 2004; Martin, 2005). Death occurs at an early age, between 12-15 years, with at 
least 90% of HGPS subjects dying from cardiovascular causes, with atherosclerosis being 
the predominant pathology (Hasty et al., 2003; Al Shali and Hegele, 2004). HGPS patients 
appear normal at birth, but within a year begin to show accelerated aging (Pollex and 
Hegele, 2004). Patients then show typical symptoms, including micrognathia (small jaw), 
craniofacial disproportion, alopecia, prominent eyes and scalp, delayed growth, short 
stature, below average weight, a lack of subcutaneous fat, wrinkled skin, speckled 
hypopigmentation, reduced bone density and a 'horse riding' stance (Mounkes and 
Stewart, 2004; Pollex and Hegele, 2004). Thus, patients seem to age up to ten years per 
every year of their life (Pollex and Hegele, 2004). However, patients do not show all signs 
"~""--
of aging, with the notable absence of any increase in tumour susceptibility, cataract 
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formation or cognitive degeneration, prompting the disease to be called a 'segmental' 
progeroid syndrome, as it does not fully recapitulate all symptoms of the normal aging 
process (Mounkes and Stewart, 2004). However, new evidence has implicated an 
association of osteosarcoma with an atypical form ofHGPS (Shalev et al., 2007) 
Classical autosomal dominant HGPS arises from a de novo mutation in LMNA that results 
in a mutant lamin A product, it does not affect lamin C, causing disastrous affects on 
nuclear architecture and genomic stability (Eriksson et al., 2003; De Sandre-Giovannoli et 
al., 2003; Cao and Hegele, 2003). In one study, 18 out of 20 classical cases of HGPS 
harboured an identical de novo point mutation 1824C> T, causing a single-base 
substitution, G608G (GGC>GGT), within exon 11 (Eriksson et al., 2003). The group also 
identified two other de novo mutations resulting in HGPS, a different heterozygous base 
substitution in the same codon G608S (GGC>AGC) and a heterozygous base substitution 
in exon 2, E145K (GAG>AAG) (Eriksson et al., 2003). Analysis of the G608G mutation 
revealed that the single base substitution led to the activation of a cryptic splice site within 
LMNA, resulting in the production of a protein that lacks an internal (pVal607-Gln656del) 
50 amino acid sequence near the C-terminus (Eriksson et al., 2003). This deletion removes 
a potential phosphorylation site, but the CAAX motif remains intact and is not expected to 
interfere with farnesylation, release of -AAX or carboxymethylation (Eriksson et a!., 
2003). However, the mutation does remove the second endoproteolytic cleavage site, 
RSY ~LLG, preventing the fmal processing step to mature lamin A, creating a mutant 
protein termed 'progerin' that is both carboxymethylated and farnesylated (Figure 4) 
(Goldman et a!., 2004). Progerin transcript levels are approximately 40% of the total 
lamin A transcripts, thus suggesting that use of the splice site is incomplete and that the 
mutant protein has a dominant negative effect (Reddel and Weiss, 2004). Fibroblasts 
from patients exhibit characteristic nuclear abnormalities such as blebbing, NPC 
clustering and even nuclear envelope ruptures with chromatin extrusions (Eriksson eta!., 
2003; Goldman eta!., 2004). A range of other mutations, both autosomal dominant and 
recessive, have been found in LMNA, giving rise to atypical HGPS (Csoka et al., 2004b; 
Fukuchi eta!., 2004; Plasilova et al., 2004; Verstraeten et al., 2006; Mazereeuw-Hautier 
eta!., 1007). Qne such,mutation"is a substitution at position 644 of arginine for a cysteine, 
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purported to alter the second endoproteolytic cleavage recognition site, and thus, like 
progerin, is both famesylated and carboxymethylated (Figure 4) (Csoka et al., 2004b). 
Notably, an autosomal recessive mutation, K542N, that causes atypical HGPS, with some 
characteristics of MAD, is located at the solvent-accessible Ig-like domain, suggesting 
different pathogenic mechanisms for the disease as compared to typical HGPS (Plasilova 
et al., 2004). 
Stem cells 
Stem cells are at the forefront of research as they represent a potential source of cells that 
may be used to replace or regenerate damaged tissues (Gharzi et al., 2003; Barrilleaux et 
al., 2006). Stem cells are distinguished by their ability to divide asymmetrically, therefore 
producing progeny that allows for its self-renewal to retain 'sternness', whilst also 
committing to a defined set of progeny capable of differentiating into various cell types 
(Weissman et al., 2001; Wobus and Boheler, 2005). Stem cells are usually classified 
according to their self-renewal and differentiation potential. Totipotent stem cells may 
form all embryonic and extra-embryonic cell types (Ciosk et al., 2006). The less potent 
pluripotent stem cells may produce any cell of the three germ layers, whilst multipotent 
stem cells may produce a subset of cell lineages and the least potent, unipotent stem cells, 
give rise only to only one type of cell (Moore and Lemischka, 2006; Hoffman and Merrill, 
2007). Human embryonic stem cells have been isolated and are subject to various 
functional regulations that allow them to self-renew, such as the expression of telomerase 
and the expression of certain transcription factors including Oct4, Nanog and SOX2, 
which actively bind promoters of genes required for growth and proliferation (Armstrong 
et al., 2000; Chambers and Smith, 2004; Armstrong et al., 2005; Boyer et al., 2005; Gan 
et al., 2007; Hiyama and Hiyama, 2007). Active repression of genes required for 
differentiation by Polycomb group complexes also occurs (Boyer et a/., 2006; Lee et a/., 
2006). Somatic, or adult, stem cells also exist within specific niches and are capable of 
maintaining, generating and replacing terminally differentiated cells within their own 
specific tissue (Nystul and Spradling, 2006). The best-characterised of these are the 
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haematopoietic stem cells (HSCs) derived from bone marrow, which are multipotent and 
give rise to blood cells (Jiang et al., 2002a,b). Furthermore, adult stem cells exist in a 
variety of adult tissues including mesenchymal stem cells (MSCs ), which are also derived 
from the bone marrow stroma, multipotent adipose-derived stem cells (hMADs), skin-
derived precursor (SKPs) stem cells, mammary stem cells, hepatic stem cells, pancreatic 
stem cells, skeletal muscle satellite cells and neural stem cells (Bjomsen et al., 1999; 
Pitteneger et al., 1999; Toma et al., 2001; Zuk et al., 2001; Jiang et al., 2002a,b; Zuk et 
al., 2002; Frockop et al., 2003; Fernandes et al., 2004; Ogawa et al., 2004; Rodriguez et 
al., 2004; Shackleton et al., 2005; Toma et al., 2005). Previous dogma stated that tissue-
specific adult stem cells would only give rise to tissue-specific progenitor cells, however, 
it is now emerging that adult stem cells have a high degree of plasticity with contribution 
across germ layers (Wagers and Weissman, 2004; Nystul and Spradling, 2006). 
Hair follicle stem cells 
The hair follicle appendage results from invagination of the epidermis during 
development, which is regulated by a host of signalling cues, including BMP, FGF, TNF, 
Wnt and sonic hedgehog signalling (Shh) pathways (Schmidt-Ullrich and Paus, 2005; 
Waters et al., 2007). Once matured, the hair follicle undergoes rounds of cycling, divided 
into three stages, namely anagen, catagen and telogen (Waters et al., 2007). During 
anagen, the relatively undifferentiated matrix cells, also known as transit-amplifying cells, 
proliferate and differentiate to generate the hair shaft and the surrounding inner root sheath 
at the base of the growing follicle, which together are comprised of at least eight different 
cell lineages (Lavker et al., 2003; Alonso and Fuchs, 2006; Cotsarelis, 2006a). Anagen 
duration is variable between species and body location (Cotsarelis, 2006b). Once this 
growth stage is complete, cells of the matrix undergo apoptosis bringing the hair follicle 
bulb into close proximity to the bulge compartment (Lavker et al., 2003; Millar, 2002; 
Muller-Rover et al., 2001). This is followed by a period of quiescence, telogen, before 
activation of cells within the hair follicle stem cell compartments initiate a new round of 
anag~e_n_ (Alonso ~and F!.!c~,~200_§);_Tw(),,~istj.J1CJ stem cell niches exist in the hair follicle 
that serves to reform the hair shaft and IRS during rounds of cycling (Jahoda, 2003; 
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Blanpain et al., 2004). The bulge region contains label-retaining multipotent epithelial 
stem cells that express distinct cell surface markers identified by gene expression profiling 
(Cotsarelis et al., 1990; Morris et al., 2004; Ohyama et al., 2006). At the onset of anagen, 
a population at the bottom of the stem cell bulge compartment is activated to divide 
rapidly which then migrate to the base of the follicle and differentiate to form the hair 
shaft and IRS (Oshima et al., 2001). The cells in the bulge then return to a quiescent state, 
rarely undergoing mitosis (Cotsarelis et al., 2006b). As well as a involvement in hair 
follicle cycling, bulge stem cells may participate in wound healing (Jahoda and Reynolds, 
2001; Ito et al., 2007) A second stem cell niche is the mesenchymal-derived dermal 
papilla, located at the base of the hair follicle and is essential for hair follicle production 
(Jahoda et al., 1984; Kishimoto et al., 2000). It has been suggested that at the telogen to 
anagen transition, the dermal papilla activates stem cells in the bulge niche, the so-called 
'bugle activation hypothesis', with crosstalk between this epithelial-mesenchymal 
interaction likely due to a combination of Wnt, BMP and Shh signaling pathways 
(Kishimoto et al., 2000; Jahoda, 2003; Alonso and Fuchs, 2003; Lowry et al., 2005; 
Alonso and Fuchs, 2006; Cotsarelis, 2006a,b; Ohyama, 2007; Tiede et al., 2007; Waters et 
al., 2007). Both bulge and dermal papilla stem cells exhibit a great degree of plasticity 
both in vitro and in vivo, giving rise to adipogenic, osteogenic, neural and haemopoietic 
lineages (Lako et al., 2002; Jahoda et al., 2003; Blanpain et al., 2004; Richardson et al., 
2005; Blanpain et al., 2007). 
Role of lamins in adult stem cells 
Early findings that A-type lamins are differentially regulated during development have 
implicated their importance in somatic tissues, being described as the 'guardian of the 
soma' (Burke and Stewart, 1987; Hutchison and Worman, 2004). Consistent with this, A-
type lamins are absent from human embryonic stem cells and LMNA knockout mice 
appear normal at birth, although with subsequent growth retardation (Sullivan et al., 1999; 
Constantinescu et al., 2006). As many of the tissues affected in laminopathies are of 
mesenchymal origin, it suggests that ther,e. may be a common disease pathogenesis that 
affects these tissues. It has therefore been proposed that laminopathic phenotypes may be 
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due to the failure of adult stem cells to self-renew and differentiate to replace damaged 
tissues, probably via the impairment of Rb-mediated pathways (Hutchison and Worman, 
2004). Indeed, overexpression of laminopathy-causing mutations causes the failure of 
C2C12 myoblasts and 3T3-Ll preadipocytes to differentiate in vitro, and gene expression 
profiling has shown disruption to the Rb-MyoD pathway in muscle regeneration (Favreau 
eta/., 2004; Markiewicz eta/., 2005; Bakay eta/., 2006; Boguslavsky eta/., 2006; Frock 
eta/., 2006; Melcon eta/., 2006). 
Current work and aims 
The failure of adult stem cells to self-renew and differentiate in laminopathies has been 
suggested to be one of the major underlying pathogenic mechanisms governing the disease 
phenotypes (Hutchison and Worman, 2004). Due to the paucity of the material required to 
test this hypothesis, it has yet to be determined whether mutations found in typical and 
atypical HGPS cause adult stem cell self-renewal malfunction or an inhibition of cellular 
differentiation in -vitro, or both. Therefore, this work sought to clarify this issue. To 
achieve this, rat dermal papilla 9 clonal adult stem cells were used to generate a stable line 
expressing FLAG-tagged prelamin A constructs harbouring mutations found in both 
typical and atypical HGPS. To assess self-renewal capacity, cells were routinely passaged 
and counted. To assay for differentiation potential, cells were exposed to adipogenic 
medium for six days. A Tet-On inducible gene expression system was also initiated so that 
future work may elucidate the role of wild type lamin A and lamin A mutants on adult 
stem cell self-renewal and differentiation in greater detail. 
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Chapter 2. Material and Methods 
Transformation of E. coli with pSVK3-FLAG-prelamin A or pEGFP-prelamin 
A 
All cloning procedures were carried out according to standard methods (Sambrook et al., 
1989). The ATG-FLAG-prelamin A eDNA has been previously cloned into the 
mammalian expression vector pSVK3 (Amersham Pharmacia Biotech Inc, Picastway, 
New Jersey, USA) which has a multiple cloning site downstream from an SV40 early 
promoter and an ampicillin resistance cassette (Ostlund et al., 2001). The construct was 
kindly provided by H.J. Worman (Departments of Medicine and of Anatomy and Cell 
Biology, Columbia University College of Physicians and Surgeons, New York, USA). 
The pSVK3-FLAG-prelamin A construct was reconstituted in 50fll of ddH20 and used to 
transform competent E. coli cells. Briefly, 1 OOfll of E. coli cells were thawed on ice for 10 
minutes. After which time, lOfll ofpSVK3-FLAG-prelamin A was added to the cells and 
mixed carefully using a pipette, then left for up to 30 minutes on ice. The cells were then 
placed at 42°C for 90 seconds, then returned to ice for exactly 2 minutes. Next, lml of 
room temperature LB was added to the cells and then incubated at 37°C for 90 minutes 
with shaking at 225-250 rpm. Cells were then plated onto LB agar containing lOOmg/ml 
ampicillin and allowed to grow for 16-20 hours at 37°C. From these plates, clearly isolated 
colonies were chosen and grown in LB with 1 OOmg/ml ampicillin for 16 hours with 
shaking at 225-250 rpm before conducting small scale DNA purification of the culture. 
Prelamin A eDNA has been previously cloned into pEGFP-C2 (Clontech Inc, Palo Alto, 
California, USA), which contains a multiple cloning site downstream from the 
cytomegalovirus early promoter and expresses the gene with a C-terminus EGFP fusion 
(Vaughan et al., 2001). A vial of frozen E. coli cells previously transformed with pEGFP-
C2-prelamin A were thawed on ice for 10 minutes, then a 20fll aliquot was transferred to 
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5ml liquid LB containing 50mg/ml kanamycin and grown for 16 hours with shaking at 
225-250 rpm before conducting small scale DNA purification of the culture. 
DNA purification 
Small-scale DNA purification (<5Jlg purified plasmid DNA) was carried out according to 
the manufacturer's guidelines (Promega Corporation, Madison, Wisconsin, USA). 
Briefly, 2ml of cells from an overnight culture were centrifuged at 10,000 x g for 5 
minutes at room temperature, resuspended (50mM Tris-HCl (pH 7.5), lOmM EDTA, 
100Jlg RNase A) and then lysed (0.2M NaOH, 1% SDS). Endonucleases and other 
contaminating proteins were then inactivated by alkaline protease treatment, followed by 
neutralisation (4.09M guanidine hydrochloride, 0.759M potassium acetate, 2.12M glacial 
acetic acid) of the protease. The bacterial lysate was then centrifuged at 16,000 x g for 10 
minutes at room temperature (all centrifugation in this method at room temperature unless 
stated otherwise). Cleared lysate was then transferred to a spin column and centrifuged at 
16,000 x g for 1 minute. A wash solution (60% ethanol, 60mM potassium acetate, 8.3mM 
Tris-HCI, 0.04mM EDTA) was then added to the spin column and in tum centrifuged at 
16,000 x g for 1 minute. This was followed by another wash but with a centrifugation time 
of 2 minutes. The plasmid DNA was then eluted by adding 1 OOJ.ll of nuclease-free water 
and centrifuging at 16,000 x g for 1 minute. Plasmid DNA was kept in a sterile 1.5ml 
microcentrifuge tube at -20°C. DNA was quantified using a Cecil GeneQuest CE 2301 
spectrophotometer at a wavelength of 260nm· 
Large scale DNA purification (up to 1mg purified plasmid DNA) was carried out 
according to the manufacturer's (Promega). Initially, a 5ml culture of transformed E. coli 
was grown for 8 hours at 37°C with shaking at 225-250 rpm. The cells were then 
transferred to 200m! of LB and the appropriate antibiotic and grown for 16-21 hours at 
37°C with shaking at 225-250 rpm. The cells were pelleted by centrifugation at 5,000 x g 
for 10 minutes using a room temperature rotor. Cells were then thoroughly resuspended 
{5_0mM Tris-HCL (pH 7.5), lOmM EDTA. (pH 8.0),, lOOJlg/ml RNase A), lysed- (0.2M 
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NaOH, 1% SDS) and then neutralised (4.09M guanidine hydrochloride (pH 4.8), 795mM, 
2.12M glacial acetic acid). The lysate was then centrifuged at 14,000 x g for 20 minutes in 
a fixed-angle rotor at room temperature. The lysate was then passed through a DNA 
binding column via a vacuum manifold. An endotoxin removal wash was passed through 
the column via by the vacuum before the addition of a column wash (60% ethanol, 60mM 
potassium acetate, 8.3mM Tris-HCl, 0.04mM EDTA), which was also drawn through the 
column by the vacuum. The column membrane was then air dried for 5 minutes by 
applying the vacuum. In order to elute the DNA, the column was placed in a 50ml 
disposable plastic centrifuge tube and then 1.5ml nuclease-free water was added to the 
column before centrifuging in a swinging-bucket rotor at 2,000 x g for 5 minutes at room 
temperature. The eluted DNA was transferred to a sterile 1.5ml microcentrifuge tube and 
stored at -20°C. DNA was quantified using a Cecil GeneQuest CE 2301 
spectrophotometer at a wavelength of 260nm· 
Site-directed mutagenesis of pSVK3-FLAG-prelamin A and pEGFP-
prelaminA 
In order to produce plasmids that would express the two mutant proteins with the 150nt 
internal deletion or the R644C point mutation, the QuickChange II Site-Directed 
Mutagenesis Kit (Stratagene, La Jolla, California, USA) was used to introduce mutations 
into the wild type pSVK3-FLAG-prelamin A and pEGFP-C2-prelamin A vectors. This 
method utilises the dsDNA prelamin A vectors and two synthetic oligonucleotide primers, 
which both contain the desired mutations to be introduced into the target insert-containing 
vectors. The complimentary primers are extended during thermal cycling by PfuU/tra HF 
DNA polymerase, which eradicates unwanted second-site errors and produces high 
mutation efficiencies. The parental DNA template is then digested with Dpn I, an 
endonuclease that recognises methylated and hemimethylated DNA. The product vector 
containing the desired mutation is then transformed into competent E.coli cells for nick 
repair. 
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Mutagenic primers were designed according to manufacturer's guidelines (Sigma Ltd, 
Poole, Dorset, UK). The LA~50 forward pnmer used was 
5' -GCGGCTCAGGAGCCCAGAGCCCCCAGAACTGCAGC-3 ', along with its 
complimentary sequence. The LA(R644C) forward pnmer used was 
5 '-GCCCAGGAGGTAGGAGCAGGTGACCAGATTGTC-3 ', along with its 
complimentary sequence. For thermal cycling, two different sample reactions were 
prepared for each vector mutation, with 1 Ong and 20ng of template dsDNA used with a 
constant primer concentration. Each sample reaction contained 125ng of both the forward 
and reverse primer and 2.5 U/Jll PfuUltra HF DNA polymerase. A positive control 
reaction containing 1 Ong of p Whitescript was also prepared. Control primers and Pfu Ultra 
HF DNA polymerase concentrations were as above. Cycling parameters for the 
mutagenesis is dependent on both the vector size and the nature of the mutation to be 
introduced into the vector. A summary of temperatures, times and cycles is provided 
below. 
Segment Cycles Temperature Time 
1 1 95°C 30 seconds 
2 *I 95°C 30 seconds 
55°C 1 minute 
68°C *L 
The number of cycles and the duration of the annealing temperature are shown below. 
Vector *1 *L. 
pSVK3-FLAG prelamin A ~50 18 6.5 minutes 
pSVK3-FLAG prelamin A (R644C) 12 6.5 minutes 
pEGFP-C2-prelamin A ~50 18 7.0 minutes 
pEGFP-C2-prelamin A (R644C) 12 7.0 minutes 
After thermal cycling, the samples were either left overnight at 4°C or cooled on ice for 2 
·to• ,--. .. '"·,· 
minutes. Each sample was digested with 10 U/Jll Dpn I and incubated for 1 hour at 37°C. 
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Transformation of E.coli cells with the digested sample was as previously described but 
with some notable exceptions. Supercompetent XL1-Blue cells were used for 
transformation, the heat shock step was 45 seconds, NZY + broth was used instead of LB 
post-heat shock, and the transformation reactions were incubated for 1 hour at 37 oc with 
shaking at 225-250rpm. The transformation reactions were then plated on agar plates 
containing the appropriate antibiotic, 1 OOmg/ml ampicillin for pSVK3-FLAG-prelamin A 
~50 and pSVK3-FLAG-prelamin A (R644C), and 50mg/ml kanamycin for pEGFP-C2-
prelamin A ~50 and pEGFP-C2-prelamin A (R644C). Plates were grown for 16-20 hours 
at 37°C, before single well-isolated colonies were picked and grown for 16 hours in LB 
plus the appropriate antibiotic. Small-scale DNA purification was then performed as 
described previously, followed by sequencing. All sequencing was performed by a 3730 
DNA Analyser (Applied Biosystems, Foster City, California, USA). Large-scale DNA 
purification was then performed as described previously to ensure DNA was of a 
concentration appropriate for transfecting cells. 
pTRE-Tight-ATG-FLAG-prelamin A-WT, L150 and R644C production 
In order to excise the ATG-FLAG-prelamin A inserts from the pSVK3 vector, pSVK3-
FLAG-prelamin A-WT, pSVK3-FLAG-prelamin A-~50 and pSVK3-FLAG-prelamin A-
R644C were each digested with 10 U/Jll Acc651 and 10 U/Jll Sal I (Promega). The pTRE-
Tight vector (Clontech) was digested with the same endonucleases at the same 
concentrations. The pTRE-Tight vector contains an MCS downstream from the Tet-
responsive Ptight promoter, which contains a minimal CMV promoter; any eDNA cloned 
into the MCS will be responsive to the rtTA regulatory protein of the Tet-On Advanced 
system. Each sample was run on a 0.8% agarose gel and the correct band was excised and 
purified from the gel according to the manufacturer's guidelines (Qiagen Inc, Valencia, 
California, USA). The ATG-FLAG-prelamin A-WT, ~50 and R644C inserts were each 
separately ligated into digested pTRE-Tight at a molar ratio of 3:1 (insert: vector) using 1 
Weiss unit of T4 DNA Ligase (Promega) and incubated for 3 hours at 22°C, before 
transformation of competent E.coli and subsequent plating, as described previously. 
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Single well-isolated colonies were grown in LB plus lOOmg/ml ampicillin for 16 hours at 
37°C with 225-250 rpm shaking. After small-scale DNA purification, the insertion 
junctions were confirmed by sequencing using the following primers (Sigma), forward 
(located at 2577-2600): 5'-AGGCGTATCACGAGGCCCTITCGT-3', and reverse 
(located at 683-660): 5'-TATTACCGCCTITGAGTGAGCTGA-3'. Large-scale DNA 
purification was then performed as previously described. 
Cell culture 
Rat clonal dermal papilla (DP) 9 and rat clonal dermal sheath (DS) 7 cells were cultured in 
MEM (Sigma) supplemented with 10% FBS (Invitrogen Ltd, Paisley, Scotland or 
Clontech) with the addition of 50 Jlg/ml gentamycin (Invitrogen) and 250 Jlg/ml 
amphotericin (Invitrogen). U2-0S Luc Tet-On Advanced cells (Clontech) were cultured in 
D-MEM containing 4.5 mg/L glucose (Invitrogen) supplemented with 10% NCS 
(Invitrogen) with 50 Jlg/ml streptomycin (Invitrogen) and 10 U/ml penicillin (Invitrogen). 
Cells were maintained in 25cm2 or 75cm2 flasks (Nunc, Rochester, New York, USA) or 
lOcm dishes (Greiner-Bio-One, Stonehouse, Gloucestershire, UK). 
Transfection and establishment of stable cell lines 
Rat DP9 cells were transfected using Amaxa Nucelofector II Technology using Primary 
Endothelial or Normal Human Dermal Fibroblast-Adult kits according to the 
manufacturer's guidelines (Amaxa AG, Cologne, Germany). Briefly, cells were grown to 
80-90% confluency, with cells passaged 3-5 days before transfection. On the day of 
transfection, cells were detached from culture flasks using 0.25% trypsin (Invitrogen), 
which was then inactivated using MEM plus 10% FBS supplemented with antibiotics. 
Cells were then thoroughly resuspended and counted using a haemocytometer to 
determine the cell density. The appropriate volume that contained 5 x 105 cells was 
centtiJuged a,t lQO x. g for 10 mip.u.t.e~s atr.oomt_empera_tux-e.Re&id:ual medium. was removed 
56 
and the pellet resuspended in 1 OOJ.1l Nucleofector Solution. The solution was then mixed 
with 5Jlg of 1Jlg/Jll DNA and immediately placed in the Nucleofector cuvette holder and 
electroporated using the program number U-23. The sample was removed and 
supplemented with MEM plus 10% FBS. For transient transfections, the sample was then 
placed in one well of a 6-well plate containing four glass coverslips and MEM plus 10% 
FBS and grown for 24 hours at 37°C in a humidified incubator with 5% C02. The media 
was replaced 24 hours later with fresh MEM plus 10% FBS, and the cells allowed to grow 
for additional 24 hours before being processed for indirect immunofluorescence. 
Alternatively, for the production of stable cell lines expressing FLAG-prelamin A WT, 
~50 or R644C, vector DNA was co-transfected with a linear hygromcyin B marker 
(Clontech) at a ratio of 10:1 (DNA: linear marker). Post-transfection, the sample was 
added to a 1 Ocm dish containing MEM plus 10% FBS. The media was replaced after 24 
hours, and after a further 24 hours 1 OOJlg/ml hygromycin B was added to the media. In all 
cases, the media was changed every 3-4 days and at all times contained 1 OOJlg/ml 
hygromycin B. Some 7-10 days post-transfection, isolated colonies had formed and plates 
were trypsinised. Cells were transferred to a 96-well plate (Nunc) at an average of 0.5 
cells per well to increase the probability of single colony production. Remaining cells 
were re-plated and grown under selective conditions until colonies had formed in the 96-
well plates. Heterogeneous stable cells that had not undergone single-cell cloning were 
then frozen down. After 3-5 days 96-well plates were examined for single colonies and 
those wells containing one colony were noted and propagated further. Mter the colonies 
had reached 70-80% confluency in one well of a 24-well plate, they were re-plated equally 
into one well of a 24-well plate containing a glass coverslip and into a single well of a 24-
well plate without a glass coverslip. Once the cells had reached approximately 70-80% 
confluency, the glass coverslip was processed for indirect immunofluorescence and judged 
for the presence of the FLAG signal, whilst the other 'stock' well was propagated. Three 
clones were then identified for each construct and cells were then grown further before 
freezing aliquots of cells before beginning adipogenic assays and determining clonal 
growth rates. 
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Rat DP9 cells were transfected as above with the pTet-On Advanced vector (Clontech) 
and were allowed to adhere for 24 hours before the growth media was replaced, and after a 
further 24 hours 350!-lg/ml geneticin (Invitrogen) was added to the media. Cells underwent 
selection, single-cell cloning and propagation, however, they were not processed for 
indirect immunofluorescence, but were instead grown to 70-80% confluency in one well 
of a 6-well plate and then re-seeded equally again into two single wells of a 6-well plate. 
One well was then processed for immunoblotting to assess the level of the rtTA protein 
expressed. Aliquots of cells were then frozen down due to time constraints. 
Indirect immunofluorescence microscopy 
Rat DP9 cells were grown on glass coverslips and fixed for 15 minutes at room 
temperature with 4% formaldehyde (AnalaR) in PBS. Cells were then permeabilised with 
0.5% Triton-X100 (Sigma) in PBS for 5 minutes at 4°C. Primary antibodies were applied 
for 1 hour at room temperature in various combinations and were diluted in 1% NCS in 
PBS. Primary antibodies used, their dilutions and sources are: mouse monoclonal LAP15 
against LAP2a [ 1:10, Dec hat et al., 1998], rabbit polyclonal RbSer780 against Rb 
phosphorylated at serine residue 780 [ 1: 100, Cell Signalling, Danvers, Massachusetts, 
USA], rabbit polyclonal RbSer807/811 against Rb phosphorylated at serine residue 
807/811 [ 1:100, Cell Signalling], mouse monoclonal Emerin [1 :50, Novacastra 
Laboratories Ltd, Newcastle-upon-Tyne, UK], mouse monoclonal anti-FLAG M2 [1:500, 
Sigma], rabbit polyclonal anti-FLAG [1:500, Sigma]. Secondary antibodies were applied 
for 1 hour at room temperature and were a combination of donkey anti-mouse IgG or 
donkey anti-rabbit IgG (both Stratech Scientific Ltd, Newmarket, UK), each conjugated to 
either tetramethylrhodarnine B isothiocyanate (TRITC) or fluorescein isothiocyanate 
(FIT C) and diluted 1:100 in 1% NCS in PBS. After washing in PBS, cells coverslips were 
mounted on to glass slides in 30% (v/v) glycerol containing 12% (v/v) Mowiol (Sigma), 
2mg/ml 4,6-diamindino-2-phenylindole (DAPI) and 2.5% (v/v) 1,4-diazobicyclo-[2.2.2]-
octane (DABCO; Sigma). Images of stained cells were taken using a Bio-Rad Radiance 
2000 confocal laser scanner(Bio-Rad Inct Herculest Califomiat USA)-attached to a-Zeiss 
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Axioskop (Carl Zeiss GmbH, Germany), which was fitted with a 40X 1.4 NA Plan 
Neofluor lens. Images were viewed and saved using LaserSharp 2000 (Bio-Rad), before 
importing into ImageJ, where images were merged before subsequent collation using 
Adobe Photoshop 7.0. Laser power was adjusted to enable comparison of the fluorescence 
signal. 
Immunoblotting 
Samples were separated by one dimensional SDS-PAGE was carried out according to 
standard protocols (Laemlli, 1970). For immunoblotting, proteins were separated on a 
12% gel and electrophoretically transferred to a nitrocellulose membrane (0.2mm, 
Whatman PLC, Brentford, UK) in 48mM Tris-HCl (pH 9.4) and 39mM glycine by using 
the Mini Transblot system (Bio-Rad). The membranes were saturated with 5% (wt./vol.) 
nonfat dry milk in TBST [50 mM Tris-HCl (pH 8.0), 138 mM NaCl, 2.7 mM KCl, 0.05% 
Tween 20] (Sigma), then incubated overnight with the primary antibody at 4°C. The 
membrane was then washed with TBST and then incubated with the secondary antibody 
for 1 hour at room temperature. The primary antibody used was mouse monoclonal TetR 
(Clontech), diluted 1:1000. The secondary antibody used was donkey anti-mouse IgG 
conjugated to horseradish peroxidise (Stratech). Immunological detection of proteins was 
performed with the Enhanced Chemiluminescence (ECL; GE Healthcare, Chalfont St. 
Giles, UK) kit and bands visualised using the LAS-1 000 imaging system (FujiFilm, 
Tokyo, Japan). 
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Luciferase assay 
U2-0S Luc Tet-On Advanced cells were plated at 0.5 x 105 per well of a 6-well plate in 
increasing concentrations of doxycycline and grown for 48 hours. Alternatively, DP9 Tet-
On Advanced clones were transiently transfected with pTRE-Tight-Luc as described 
previously, and grown for 48 hours in 1 OOnglml doxycycline. Luciferase activity was then 
assayed using the Dual-Luciferase Reporter Assay System according to the 
manufacturer's guidelines (Promega). Luminescence was measured using a Lumat LB 
9507 luminometer (Berthold Technologies GmbH, Bad Wildbad, Germany). 
Determination of cell growth 
Each clone was plated at 70,000 cells per 60mm culture dish (Greiner-Bio-One) and 
passaged every 3 or 4 days, with cell growth calculated as population doubling potential, 
using the formula, (log N1-log N2) I log 2.0. Where N 1 is the cell number counted after 3 
or 4 days and N2 is the number of cells seeded after each passage, which was 70,000 per 
clone. Regression line analysis was carried by the 'line of best fit' function in Microsoft 
Excel. 
· Adipogenic assay 
Rat DP9 and DS7 cells were subjected to two different methods that have previously been 
reported to differentiate either rat clonal DP and DS cells or 3T3-L1 preadipocytes in 
vitro. The first method was adapted from Jahoda eta/., 2003. Both DP9 (p21) and DS7 
(p35) were plated in duplicate at 40,000 cells per 35-mm dish (Nunc) and allowed to 
adhere overnight in MEM plus 10% FBS at 37°C in a humidified incubator with 5% C02. 
The next day, adipogenic medium (MEM plus 15% rabbit serum, 2.07mM insulin and 
1 OOnM dexamethasone) was added to one of each pair of DP9 and DS7 clones, whilst the 
other·pair was resupplemented· with growth media, -MEMcplus 10% FBS, as a control. 
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Thereafter, the media was changed every two days with either growth media or adipogenic 
media as appropriate, and the cultures maintained for six days in total from the point of 
addition of the adipogenic media. 
The second method that was employed was adapted from Boguslavsky et al., 2006. Both 
DP9 (p21) and DS7 (p35) were plated in duplicate at either 40,000 or 100,000 cells per 
35-mm dish and allowed to adhere overnight in MEM plus 10% FBS at 37°C in a 
humidified incubator with 5% C02• The following day, adipogenic medium (DMEM plus 
10% FBS, 1mM insulin and 1mM dexamethasone) was added to one of each pair of DP9 
and DS7 clones, whilst the other pair was resupplemented with MEM plus 10% FBS as a 
control. After two days, a secondary adipogenic medium (DMEM plus 10% FBS, 1mM 
insulin) was added to one of each pair, whilst growth media was added to the controls. 
Both sets of media were replaced after two days with respective fresh media for an 
additional two days thereafter, giving a total of six days under growth or adipogenic 
conditions. 
Having established a method for the in vitro differentiation of untransfected DP9 cells, it 
was decided to pursue the first method when performing adipogenic assays with the DP9 
prelamin A wild type, ~50 and R644C stable cell lines. The only alteration from the 
method above is that 100mg/ml hygromycin B (Clontech) was present in the growth and 
adipogenic media at all times. 
Lipid detection 
After six days under culture conditions, cells were stained with oil red-O to detect 
intracellular lipid accumulation. The culture medium was removed and cells were washed 
once in PBS, and then fixed in calcium formol ( 4% formaldehyde, 1% calcium chloride) 
for 1 hour at room temperature. The cells were incubated for 15 minutes with a filtered 
solution of three parts of saturated oil red-O in isopropanol and two parts ddH20. The 
stained cells . were then washed once . with 60% isopropanol, . washed thoroughly with 
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ddH20, and then overlaid with PBS. Plates were then scanned into Adobe Photoshop using 
a ScanJet 6300C (Hewlett Packard). 
Semi-quantitative analysis of Oil Red-O 
Oil red-O dye was extracted by submerging the plates in 4% SDS in 60% isopropanol for 
15 minutes at room temperature. The optical density of the oil red-O was measured in a 
Cecil GeneQuest CE 2301 spectrophotometer at a wavelength of 370nm· Percentage of 
differentiation of each clone was expressed as a percentage of the OD370nm of wild type 
DP9 after 6 days under adipogenic conditions. Results were assessed for significance 
using a Student's t-test. 
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Chapter 3. Results 
Introduction 
Structural defects to the nuclear envelope have been well documented in cells containing 
lamin mutations, although the extent is somewhat variable, depending on the position of 
the mutation (Broers et a/., 2006). Fibroblasts from HOPS patients show symptomatic 
nuclear abnormalities as do both human fibroblasts and HeLa cells transiently transfected 
with a GFP-tagged progerin construct (Eriksson eta/., 2003; Goldman eta/., 2004). These 
structural abnormalities are protein concentration dependent and include nuclear pore 
clustering, a loss of heterochromatin and lobulations of the nuclear envelope (Goldman et 
al., 2004). At present, no study has addressed the effect of transiently overexpressing 
progerin in adult stem cells, presumably due to the difficulty in obtaining such material. 
Yet, it has been proposed that it is a necessary requirement that there should be 
functioning A-type lamins ·in maintaining the proliferative state and inductive potential of 
adult stem cells in order to retain the ability to repair old or damaged tissues (Hutchison 
and Worman, 2004). Therefore, constructs were made that expressed both FLAG- and 
GFP-tagged prelamin A and two mutants associated with typical and atypical HOPS, 
prelamin A ~50 (LM50) and prelamin A R644C (LA(R644C)) respectively. The LA~50 
mutant has a 50 amino acid internal deletion V607 through Q656, whilst the LA(R644C) 
mutant has an arginine substituted at position 644 for a cysteine (R644C). These 
constructs were then transiently overexpressed in adult rat clonal DP9 cell and processed 
for indirect immunofluorescence. 
Transient overexpression of two mutants associated with premature aging 
causes nuclear abnormalities in adult stem cells. 
Nuclei were counted by observing those present in a randomly selected microscopic field 
:;,.- of view (where n = 200). Nuclei were counted only if wild type or mutant lamin A was 
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expressed in cells, as judged by either anti-FLAG antibody or by fluorescent signal. 
Nuclei were deemed to be morphologically 'normal' if the nuclear envelope was ellipsoid 
in shape with no perturbation to the peripheral envelope and with only a faint internal 
signal. Contrastingly, nuclei showing structural abnormalities after 72 hours post-
transfection could be further sub-classified according to the nature of the abnormality 
observed (Figure 6). Of these, nuclei were classified as having 'trans-nuclear' lamin 
structures if they presented at least two lamin tubule-like structure, which transverses the 
nuclear envelope. Those nuclei established as having 'intra-nuclear' structures showed 
prominent aggregates of lamin A protein within the nucleus. Small lamin positive 
ellipsoid microstructures were found next to 'parent' nuclei and these were termed 
'micronuclei'. The last defect observed was an 'invagination' or 'blebbing' ofthe nuclear 
envelope, whereby the nuclear envelope showed a distinct abhorrent morphology with 
either lobulation of the envelope or indentations. 
Normal Nuclear abnormalities 
Micronuclei Blebs/ Trans- and intra-
nuclear structures Invagination 
Figure 6. Micrograph of nuclear abnormalities found in transfected DP9 cells. Nuclei 
were classified as 'normal' ifthey had correct nuclear envelope staining. Nuclei classified 
as 'abnormal' presented one of four major nuclear abnormalities, found from 
overexpressing mutant lamin A in both FLAG- and GFP-tagged expression constructs. 
(Scale, 10~) 
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Each nucleus scored as 'abnormal' was noted for its most prominent abnormality. If a 
nucleus presented more than two of the above abnormalities, then its classificiation was 
decided by the following order: micronuclei > blebbing/invagination = intranuclear 
aggregates > transnuclear. As micronuclei appeared to be the most severe abnormality this 
was placed fust, whilst the blebbing/invagination and intranuclear aggregates were placed 
joint second as they were never seen in the same cell. 
Upon transfection with both FLAG-tagged and GFP-tagged LA~50 and LA(R644C), 
there was a notable increase in the percentage of nuclear abnormalities in the DP9 cells 
after 72 hours as compared with DP9 cells transfected with either FLAG- or GFP-tagged 
wild type laminA (Figure 7A). The highest percentages of abnormalities were found in 
both FLAG- and GFP- tagged LM50 cells, with both showing similar numbers of 
abnormalities, 56% vs. 59% (Figure 7A). Although DP9 cells showed less abnormalities 
when overexpressed with LA(R644C), comparison between the FLAG- and GFP-tagged 
constructs yielded similar results, 49% vs. 48% (Figure 7A). These results confirm earlier 
reports that overexpression of two mutants associated with premature aging cause 
structural defects in the nuclear envelope, although these are the fust observed in adult 
stem cells (Goldman et al., 2004; Csoka et a/., 2004b). However, even for DP9 cells 
transfected with the wild type FLAG- and GFP-tagged lamin A protein, there were nuclear 
envelope abnormalities detected in high numbers of cells, at 15% and 17% respectively, 
indicating that the high concentrations of exogenously expressed wild type lamin A may 
have toxic effects upon nuclear envelope structure (Figure 7A). Taken together, these 
results suggest that not only is a functional lamin A protein essential for maintaining 
nuclear envelope integrity, but also the concentration at which it is present in the nucleus 
is important to maintain nuclear envelope stability. Despite this, it should be noted that the 
majority of cells expressing either the FLAG- and GFP-lamin A mutants still retained a 
normal nuclear envelope structure with the prelamin A being processed into the nuclear 
envelope, based on microscopic study, which is consistent with previous reports 
(Goldman et al., 2004). 
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Figure 7. Analysis of nuclear abnormalities found in DP9 cells transfected with mutant 
lamins associated with premature aging. Cells were classified as 'normal' or 'abnormal' 
based on nuclear envelope structure (A). Notice that overexpression of both FLAG- and 
GFP-tagged mutant lamins associated with premature aging caused an increase in the 
number of nuclear abnormalities in DP9 cells. Nuclei classified as 'abnormal' from the 
results in (A) were then categorized according to their nature (B). 
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Of the nuclei classified as 'abnormal' during the initial count of 200 nuclei, further 
detailed analysis was performed using confocal microscopy and categorized according to 
their nature as set out in Figure 6 (Figure 7B). The progerin protein is both 
carboxymethylated and farnesylated and is therefore expected to integrate into the nuclear 
lamina, as has been shown here and in other studies (Figure 6) (Dechat et a/., 2007). 
Furthermore, the characteristic bleb bing of the nuclear envelope was present in DP9 cells 
transfected with both FLAG and GFP-tagged LAd50 (Figure 7B). As this defect has 
already been noted in previous studies, further attention was made to the other nuclear 
abnormalities observed. 
Cells transfected with FLAG- or GFP-tagged wild type LA that were noted as having a 
nuclear abnormality predominantly contained transnuclear structures (both 9% of total 
cells), as has been shown previously for overexpression of chimeric GFP-lamin A 
constructs in CHO-Kl cells (Figure 7B) (Broers eta/., 1999). Similarly, these structures 
were also prominent, albeit to a greater extent, in cells overexpressing LAd50, either with 
a FLAG or GFP-tag (21% vs. 35% of all cells, respectively) (Figure 7B). In order to 
investigate further the nature of the transnuclear structures, Z-series were generated using 
15 frames with a step siz~ of 0.25f..liil in the Z-direction. Images were then split and 
assembled into sequential Z-sections (Figure 8). The transnuclear lamin structures extend 
from the top of the cell and penetrate deep into the core of nucleus (Figure 8, A-C), and 
also from the bottom to the core of the nucleus (Figure 8, D-F), suggesting that these are 
deep extensions of the nuclear envelope rather than accumulations of lamin protein within 
the nucleoplasm. 
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Figure 8. Transnuclear lamin structures. A series of images were taken along the Z-
direction revealing that tubule-like lamin A structures penetrate deep within the centre of 
the nucleus with overexpression of lamin A~50, from both the top (A-C) and the bottom 
(D-F) of the cell. (Scale 1 OIJlll) 
In contrast, fewer transnuclear lamin structures were found in DP9 cells transfected with 
the LA(R644C) constructs, with the predominant nuclear abnormality being intranuclear 
aggregates oflamin A protein (Figure 7B). Nuclear aggregates oflamins have been widely 
reported previously for various mutations (Schmidt et al., 1994; Izumi et al., 2000; 
Ostlund eta/., 2001; Rahaijo eta/., 2001; Vaughan et al., 2001; Markiewicz et al., 2002b; 
Holt eta/., 2003). A montage of Z-series images revealed that the intranuclear aggregates 
were present throughout the entire nucleus, and whilst some of the aggregates localised to 
the nuclear envelope, there was an absence of mutant lamin A protein assembled into most 
parts of the nuclear periphery (Figure 9). 
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Figure 9. Intranuclear lamin A aggregates. A series of images taken in the Z-direction 
show that overexpression of lamin A(R644C) cause the formation of intranuclear 
aggregates that are not extensions of the nuclear envelope, but are discrete lamin A foci 
that prevent the correct incorporation of lam in A into the nuclear envelope. (Scale 1 OJ.Ul1) 
To help define further the nuclear abnormalities found in DP9 cells transfected with lamin 
mutants, cells were stained for emerin, which is a protein known to localise to the inner 
nuclear membrane (Nagano et al. , 1996). In cells transfected with FLAG-LA, emerin 
colocalised with the anti-FLAG signal at the INM as expected (Figure lOA). However, 
emerin did not colocalise fully with FLAG-LA.0.50 when found to accumulate in 
intranuclear aggregates (Figure 1 OB). 
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FLAG Emerin Merge 
Figure 10. Emerin does not colocalise with intranuclear mutant lamin A. DP9 cells 
overexpressing FLAG-tagged LA show correct colocalisation with emerin, an INM 
protein (A). However, DP9 cells overexpressing FLAG-LAL\50 that results in the presence 
of intranuclear lamin structures does not co localise with emerin (B). (Scale 1 O)!m) 
This is reinforced by instances where overexpression of both GFP-LAL\50 and GFP-
LA(R644C) caused the accumulation of intranuclear aggregates; again, emerin stained the 
nuclear envelope, but did not co localise with the lamin aggregates (Figure 11 C,E,F). 
Nuclear rim staining with a concomitant presence of intranuclear aggregates for GFP-
R644C was found to be variable (Figure llE,F, G). Staining was either present at the 
nuclear rim (Figure 11 G), clustered at some regions (Figure 11E) or largely absent or at 
low levels (Figure 11F). 
In contrast to intranuclear lamin aggregates, transnuclear lamin structures found in DP9 
cells transfected with GFP-LA and GFP-LA (R644C) did colocalise with emerin, which 
suggested complete incorporation into the nuclear lamina (Figure 11A,B, G). Moreover, it . 
suggested that transnuclear lamin structures are actually an extension of the nuclear 
envelope rather than stand-alone lamin structures within the nucleus and as such are 
distinct structures from the intranuclear aggregates, both in terms of morphology and the 
assembly pathway of the protein (Schmidt et al., 1994; Pugh et al., 1997). This further 
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underlines the earlier result suggestion that these transnuclear lamin structures penetrate 
deep into the nucleus (Figure 8). 
The nature of the formation of micronuclei was also analysed. In all circumstances, 
regardless of construct or tag, micronuclei were DAPI positive and contained 
colocalisation of an anti-FLAG or fluorescent signal with emerin (Figure 11D). The 
presence of these structures displayed a general trend of being greater in cells transfected 
with mutant constructs, although they were also present in cells transfected with wild type 
constructs (Figure 7 B). The co localisation of the lamin protein with emerin suggests that 
the lamin protein was first incorporated into the lamina, before subsequently being 
expelled out of the 'parent' nuclei. 
Emerin is dependent on A-type lamins for INM localisation, therefore mutant lamin A 
colocalisation with emerin in micronuclei and transnuclear lamin structures suggests that 
the interaction between emerin and the mutant lamin A is not affected, at least at the 
microscopic level (Sullivan et al., 1999; Vaughan et al., 2001 ). Secondly, it draws a 
distinction between micronuclei and transnuclear lamin formation on one hand, ·and 
intranuclear aggregate lamin A formation on the other, as the latter does not colocalise 
with emerin, suggesting that the mutant protein does not incorporate into the lamina and 
remains within the nucleoplasm as an immobile aggregate. Interestingly, the nuclear lamin 
aggregates occurred more often in cells transfected with the LA(R644C) construct, than 
with the LM 150 constructs. It remains to be seen why this is so as the LA(R644C) 
mutant is expected to be both famesylated and carboxymethylated, the same as the LM50 
mutant. 
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Figure 11. Overexpression of mutant lamins in DP9 cells causes redistribution of emerin. 
GFP-LA colocalised with emerin (A,B), whilst there was either no localisation with 
emerin when intranuclear lamin aggregates were present ( C,F) or there was a 
redistribution of emerin into mutant lamin A positive micronuclei (D,E) when GFP-LA 
mutants were overexpressed in DP9 cells. Conversely, some GFP-LA mutant cells showed 
co localisation (G). (Scale 1 O)llll) 
GFP Ernerin Merge 
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Lamin A has been reported to be a binding partner of hypophosphorylated Rb after in 
vitro binding assays, through the latter's large pocket domain (Mancini eta!., 1994; Ozaki 
et al., 1994). Furthermore, lamin A interacts with an isoform of the LAP2 family of 
proteins, LAP2a (Dechat et a/., 2000a). Further characterisation of this complex of 
proteins revealed that LAP2a binds to Rb within a region spanning pockets B and C, with 
lamin A-LAP2a complexes required for Rb function (Markiewicz eta/., 2002b). Indeed, 
LMNA null mice show altered Rb dynamics, with mislocalisation of the protein and 
ultimate degradation by the proteasome (Johnson et al., 2004). This has led to the 
suggestion that lamin A-LAP2a-Rb complexes may play a crucial role in laminopathies, 
where this complex may be disrupted with consequences for cell growth and division 
(Hutchison and Worman, 2004; Gotzmann and Foisner, 2005). Therefore, cells transfected 
with both FLAG- and GFP-tagged lamin A and two mutants were processed for 
immunofluorescence with LAP2a or Rb antibodies. 
DP9 cells transfected with FLAG-tagged lamin A and two mutants did not reveal any 
differences in LAP2a localisation (Figure 12, A-C). Moreover, expression levels of the 
FLAG-tagged constructs did not have any immediate effect on localisation of LAP2a 
(compare the two FLAG-expressing cells in Figure 12A). Overexpression of GFP-tagged 
wild type and mutant lamin A constructs yielded similar results to those overexpressing 
FLAG-tagged constructs (Figure 12 D-G). Localisation of LAP2a in GFP-LA DP9 cells 
was uniform across the nucleus, with the exception of nucleoli, where it was absent 
(Figure 12D). Even in DP9 cells overexpressing GFP-LM50 and presenting the 
characteristic blebbing of primary HGPS fibroblasts, LAP2a was localised across the 
nucleus in a uniform manner (Figure 12B,E,F). Confirming this, DP9 cells overexpressing 
GFP-LA(R644C), which contained intranuclear aggregates, did not mislocalise LAP2a 
into the aggregates themselves (Figure 12G). These results suggest that overexpression of 
lamin A and two premature aging mutants do not affect the interaction between LAP2a 
and endogenous lamin A/C, as implied from the correct localisation of LAP2a, or if they 
do then it is at a level that is subtler than can be assessed by microscopy. These results are 
in contrast to earlier reports that have shown that LAP2a is sequestered into intranuclear 
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aggregates m cells transfected with specific lamin mutants (Dechat et al., 2000a; 
Markiewicz et al. , 2002b). 
Figure 12. LAP2a distribution is not affected by transient overexpression of FLAG- or 
GFP-tagged lamin A mutants. DP9 cells displaying nuclear abnormalities caused by 
overexpressing LAL150 or LA(R644C) with either blebbing/invaginations (B,F) , 
micronuclei ( C,E) or intranuclear lamin aggregates (G), showed no unusual distribution of 
the nucleoplasmic protein LAP2a. (Scale lOJ..l.m) 
FLAG LAP2alpha Merge 
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Cells transiently overexpressing FLAG- or GFP-tagged constructs were also costained for 
the lamin A-binding retinoblastoma susceptibility protein, Rb. A form of Rb 
phosphorylated at serine residue 780 was examined in cells transfected with FLAG- and 
GFP-tagged constructs. Rb is phosphorylated by cyclin D-CDK 4,6 complexes at the G1.:S 
phase transition, followed by further phosphorylation by cyclin E-CDK 2 heterodimers 
and remains phosphorylated until the end of M phase whereupon it is dephosphorylated by 
all three isoforms of protein phosphastase 1, allowing it to resume its repressive function 
(Mittnacht et al., 1997; Vietri et al., 2006). The serine residue 780 is known to be one of 
the frrst sites phosphorylated at the end of G1 (Lundberg and Weinberg, 1998). In the 
current study discrete loci of RbS780 were found in cells, therefore suggesting that they 
were inS or G2/M phase (Figure 13). Cells transfected with FLAG-LA constructs showing 
intranuclear (Figure 13A,B) or transnuclear (Figure 13C) lamin structures also showed a 
degree of colocalisation with the RbS780 foci. Additionally, RbS780 was also found in 
nuclear blebbing (Figure 13C). These observations were supported by transfection with 
GFP-tagged lamin constructs, as cells that contained nuclear abnormalities still contained 
RbS780 foci (Figure BE). Analysis of the foci did not reveal any differences between the 
number of RbS780 foci and the level of expression of the constructs (Figure 13D), and 
also the construct used for transfection. However, the sizes of the foci were slightly 
smaller in DP9 cells expressing either of the two lamin A mutants as compared to DP9 
cells expressing wild type laminA (Figure 13). 
These fmdings are somewhat surprising for a number of reasons. Firstly, that RbS780 
should be found as foci within cells, as it has been reported that this phospho-isoform of 
Rb usually has a uniform distribution throughout the nucleus when cells are in S or G2/M 
phase (Pevokic et al., 2007). This discrepancy may be accounted for the by the difference 
in the origin of the cell type, as previous studies have utilised human or mouse fibroblasts, 
or the antibody may recognise different phospho-isoforms of Rb. Secondly, that lamin A 
should colocalise with a hyperphosphorylated form of Rb is also surprising, given that it 
has been reported that only a hypophosphorylated form of Rb is tethered to the nucleus by 
the lamin A/C-LAP2a complex (Markiewicz et al., 2002b). This result suggests then that 
overexpression of lamin A may hinder the ability of phosphorylated Rb to be released 
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from this complex, or that the mechanistic basis of this process is different between 
species. Additionally, that the phosphorylated form of Rb should be found within the 
interior of the blebbing of the nuclear envelope underlines earlier results in this report 
suggesting that the these nuclear abnormalities are continuous with the nuclear envelope. 
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Figure 13. Overexpression of FLAG- and GFP-tagged lamin A mutants does not prevent 
RB . phosphorylation of serine residue 780. DP9 cells showed discrete foci of 
retinoblastoma protein phosphorylated at serine residue 780, which appeared to show a 
degree of colocalisation with lamin A (A,D). This was irrespective of the construct used 
and they were also present in cells with nuclear abnormalities, either blebbing (B,E) or 
transnuclear lam in structures (C). The foci of Rb phosphorylated at serine residue 780 
appeared to be smaller in cells expressing mutant laminA (B, C). (Scale 1 OJ.!m) 
FLAG RbS780 Merge 
79 
GFP RbS780 Merge 
-
80 
Co-staining with an antibody that recognised a different phospho-isoform of Rb, 
phosphorylated at serine residue 807/811, gave a different pattern of localisation to the 
RbS780 isoform (Figure 14). Cells overexpressing GFP-LA showed a relatively uniform 
pattern of distribution localised across the nucleus (Figure 14A), as did DP9 cells 
overexpressing either the GFP-LA~50 or GFP-LA(R644C) constructs, regardless of the 
presence of nuclear envelope bleb bing and intranuclear aggregates (Figure 14B, C). There 
was no difference in expression levels of RbS807/811 between GFP-LA and non-GFP 
expressing cells, showing that overexpression of wild type lamin A did not affect Rb 
phosphorylation (Figure 14A). Similar results were obtained from transiently expressing 
GFP-LM50, but there was a reduced level ofRbS807/811 in DP9 cells expressing GFP-
LA(R644C) as judged by signal intensity (Figure 14B,C). However, as expected, 
phosphorylated Rb was absent from cells exiting M and entering G1 phase (Figure 14D). 
This last result is significant as it shows that, although being a transformed cell line, the 
DP9 cells are still subject to regulatory cell-cycle-dependent events (Akagi, 2004; Ahuja 
et al., 2005). Taken together, these results infer that transient overexpression oflamin A or 
LM50 does not affect the process of Rb phosphorylation and therefore do not inhibit the 
G 1-S phase transition in DP9 cells after 72 hours, whereas transient overexpression of 
LA(R644C) may cause a reduction in the cellular ability to phosphorylate Rb at serine 
residue 807/811. 
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GFP RbS807/811 Merge 
Figure 14. GFP-LA(R644C) may disrupt phosphorylation of Rb at serine 807/811. Rb is 
phosphorylated at serine residue 807/811 in a cell cycle-dependent manner (A), and 
overexpression of GFP-LA~50 (B) does not prevent this. In contrast, there is less Rb 
phosphorylated at serine residue 807/811 in DP9 cells expressing GFP-LA(R644C) (C). 
The absence of a phosphorylated form of Rb suggests transition into 0 1 phase of the cell 
cycle and suppression of S-phase genes (D). (Scale 1 OJlm) 
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Generation of a stable stem cell line overexpressing lamin A, lamin AL150 
and lamin A(R664C). 
In order to investigate the effect that continued overexpression of lamin A may have on 
the ability for adult rat clonal stem cells to differentiate and replicate in vitro, rat DP9 cell 
lines were created that stably express either FLAG-prelamin A WT, FLAG-prelamin A 
~50 or FLAG-prelamin A(R644C). Adult rat clonal DP9 cells have previously been well 
characterised. They are fibroblast-like in appearance and have been shown to be have the 
ability to be directed towards an both an osteogenic and adipogenic lineage (Jahoda et al., 
2003). Furthermore, human dermal papilla cells have been shown to have the ability to be 
directed towards both adipogenic and osteogenic lineages. Interestingly, this inductive 
potential is retained after serial passaging in vitro and is also retained regardless of the age 
of individual (Richardson et al. , 2005). Human dermal papilla cells would have been the 
preferred choice of cell type as the differences between mouse and human models with 
regards to studying laminopathies has been well documented (Stewart et al., 2007). 
However, these have been known to senesce and/or undergo increased apoptosis early in 
culture and thus do not represent a robust cell model for the necessary adipogenic and 
growth assays required after transfection, single-cell cloning and subsequent expansion 
(Figure 15). 
hDP p8 hDP p9 
Figure 15. Human dermal papilla cells show reduced self-renewal potential with serial 
passage. The number of human dermal papilla cells, as viewed at x lO (inset, x20), is 
reduced with serial passage, indicating that they senesce early or undergo high rates of 
apoptosis under in vitro conditions. 
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In contrast, rat DP9 cells are transformed adult stem cells and therefore maintain the 
ability to self-renew with continued passaging in vitro. As a result, adult rat clonal DP9 
cells were co-transfected with constructs expressing the WT, ~50 or R644C prelamin A 
eDNA together with a linear hygromcyin B marker. After selection with hygromycin B, 
antibiotic-resistant cells were plated in 96-well plates, with single colonies expanded and 
then processed for indirect immunofluorescence. Expression levels of lamin A WT, ~50 
or R644C were slightly variable, but anti-FLAG signal was detected at the nuclear 
periphery (Figure 16). An aliquot of these nine clones were frozen down, and the 
remaining cells used for proliferation and differentiation assays. 
Lamin A 
WT 
Lamin A 
delta 150 
Lamin A 
R644C 
Figure 16. Clonal expression levels. Relative expression levels of three clones each of 
DP9 cells overexpressing either FLAG-LA, FLAG-LA~50 or FLAG-LA(R644C) as 
judged by indirect immunofluorescence. (Scale bar 1 OJ.tm) 
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Overexpression of two lamin A mutants associated with premature aging in 
adult stem cells inhibits their growth potential. 
Adult tissues contain stem cells capable of both self-renewal and differentiation, allowing 
for the maintenance of specific tissue lineages (Wagers and Weissman, 2004). As mitotic 
cells, these adult stem cells are susceptible to a cell-division-dependent increasing 
probability of acquiring a mutation that may drive them towards senescence or apoptosis 
(Campisi, 2005). It has already been reported that HGPS fibroblasts show a growth profile 
whereby cells have a hyperproliferative growth potential in earlier passages, followed by a 
swift dramatic decline and route into early senescence as compared with control fibroblast 
cultures (Bridger and Kill, 2004). This result has been used to suggest that adult stem cells 
in laminopathy patients might show reduced ability to self-renewal, therefore inhibiting 
the ability for the tissue to regenerate in response to damage (Hutchison and Worman, 
2004). Thus, in order to investigate whether the self-renewal capacity or growth potential 
of adult stem cells overexpressing LM50 or LA(R644C) is affected with serial passage, 
the nine clones created above were routinely passaged and the accumulated population 
doubling potential calculated (Figure 17A,B). The population doubling time is derived 
from the middle of the exponential growth phase and is an average figure that applies to 
the whole population, thus it includes a variety of cell division rates within the population 
and also cells that are undergoing apoptosis or senescence. 
Untransfected DP9 cells showed a steady-state growth profile, as one might expect from a 
transformed cell line, whereby similar numbers of cells were counted after each passage, 
with the regression line almost linear (Figure 17B Linear [DP9 Untransfected]). 
Similarly, continued overexpression of FLAG-LA wild type resulted in an almost linear 
doubling potential, although perhaps the toxic effect of continued overexpression of wild 
type lamin A is reflected in the slightly decreasing regression line (Figure 17 B Linear 
[DP9 Wild Type}). Continued passing of cells would clarify this question. Furthermore, 
the population doubling was at a lower level than the untransfected cells, implying that 
cell proliferation was slower than untransfected DP9 cells, which suggests that continued 
> -
overexpression of wild type lamin A has a inhibitory effect on growth pathways. 
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In contrast, both DP9 cells stably overexpressing FLAG-LM50 or FLAG-LA(R644C) 
showed a growth profile exhibiting a higher population doubling potential at an earlier 
passage number, with a notable decline in doubling potential with increasing passage 
number, which was greater for FLAG-LM50 than it was for FLAG-LA(R644C) (Figure 
17A). These results are consistent with previous reports showing that primary fibroblast 
from patients with typical HGPS exhibit a hyperproliferative growth profile followed by a 
decline in growth potential with increased rates of apoptosis (Bridger and Kill, 2004). At 
this stage, however, it is not clear whether the driving force behind this decline in 
population doubling potential for both mutants is due to increased rates of apoptosis or 
due to an increase in the number of senescent cells within the populations, further work is 
required. Taken together, these preliminary results indicate that continued overexpression 
of two lamin A mutants associated with premature aging inhibits the growth potential of 
adult stem cells. 
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Figure 17. Overexpression of two lamin A mutants associated with premature aging 
inhibits stem cell growth potential. Untransfected DP9 cells have a constant accumulated 
doubling potential, whilst DP9 cells stably overexpressing wild type FLAG-LA have a 
similar profile (A). In contrast, DP9 cells stably overexpressing FLAG-LA~50 or R644C 
show a heightened proliferative capacity at earlier passage numbers with a notable decline 
with serial passaging (A). Regression line analysis of data from (A) is shown together with 
the gradient and R2 values (B). 
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Establishment of an in vitro method for the differentiation of adult stem cells. 
To investigate the effect of overexpressing prelamin A and two mutants associated 
premature aging on the ability of adult stem cells to differentiate, adipogenesis was chosen 
as a model for a number of key reasons. Firstly, rat clonal stem cells and human dermal 
papilla have been shown to have the capacity to differentiate in vitro towards adipogenic 
and osteogenic lineages, and thus provides an essential positive control (Jahoda et a/., 
2003; Richardson et al., 2005). Secondly, adipogenesis is a well-defined series of events 
coordinated by the regulation of transcription factors, which can be replicated in vitro by 
the addition of an "empirically derived cocktail" of chemicals that induces cells towards 
differentiation into adipocytes (Darlington, 1998; MacDougald and Mandrup, 2002; Feve, 
2005; Rosen, 2005; Ailhaud, 2006; Bengoechea-Alonso and Ericsson, 2007). 
In order to establish a method for the in vitro differentiation of adult stem cells 
overexpressing FLAG-tagged lamin A constructs, two different adipogenic media were 
used for untransfected rat DP9 and DS7 cells. Although it has been previously shown that 
rat clonal stem cells differentiated according to a defined adipogenic media (Jahoda et al., 
2003), another report has used a different adipogenic media to study the differentiation of 
3T3-L1 preadipocytes overexpressing FLAG-tagged laminA constructs (Boguslavsky et 
al., 2006). Cells were and grown for six days in one of the two media, with a media 
change every two days, before being fixed and stained for intracellular lipid accumulation. 
Both DP9 and DS7 cells showed no spontaneous differentiation after six days in growth 
media, as judged by the absence of oil red-O staining (Figure 18 A,B [both GM]). In 
contrast, both DP9 and DS7 cells exposed to an adipogenic media adapted from Jahoda et 
al. (2003) exhibited considerable accumulation of intracellular lipids after six days, with 
notably more oil red-O staining for DP9 cells than DS7 cells (Figure 18 A,B [both AM]). 
DP9 and DS7 cells both reached confluency within the first 3 days under both growth and 
adipogenic conditions (Figure 18 C,D [Day 3 }). Both DP9 and DS7 cells continued to 
undergo mitosis until day six in groWth conditions, as judged by the presence of the 
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brightly emitting dividing cells (Figure 18 C,D [GM,Day 6]), whereas there was a 
cessation of mitosis from day 3 onwards under adipogenic conditions for both DP9 and 
DS7 cells (Figure 18 C,D [AM,Day 6]) as the cultures had presumably undergone clonal 
expansion and had entered the differentiation step of adipocyte development (Agarwal and 
Garg, 2006). Staining with oil red-O revealed that accumulation of intracellular lipids was 
not uniform in distribution but rather exhibited some localised areas that showed 
significantly more staining than surrounding cells (Figure 18 C,D [Oil red-O]). 
In contrast, DP9 and DS7 cells exposed to the adipogenic media adapted from 
Boguslavsky et a/. (2006) showed a distinct lack of intracellular lipids (Figure 19). Again, 
no spontaneous differentiation occurred, as reflected by the absence of intracellular lipids 
in cells after six days of growth conditions (Figure 19 A,B(GM)). DS7 cells failed to 
differentiate at all under adipogenic conditions at two different initial cell densities (Figure 
19 B(AM)). However, DP9 cells did accumulate a small amount of intracellular lipids, 
although this was barely detectable (Figure 19 A(AM)). Taken together, both these results 
reaffirm previous reports that adult stem cells from the hair follicle have the capacity to 
differentiate in vitro and can be directed towards an adipogenic lineage. Furthermore, it 
reveals that differing culture conditions may impact on stem cell fate. Based on these 
results, the adipogenic media adapted from Jahoda et a/. (2003) was employed for 
adipogenic assays involving clones overexpressing FLAG-tagged prelamin A constructs. 
89 
Figure 18. Hair follicle stem cells can be directed towards an adipogenic lineage in vitro. 
DP9 (A) and DS7 (B) cells accumulate intracellular lipids after six days in adipogenic 
culture conditions, indicating that they have undergone a program of differentiation. Note 
that no spontaneous differentiation occurred after six days in control growth medium. 
Phase contrast images reveal a halt in mitotic activity before a programme of 
differentiation, leading to intracellular accumulation of lipids in DP9 (C) and DS7 (D) 
cells after six days of adipogenic conditions. Mitotic cells are shown by an arrow (C). 
(Scale 200)lm) 
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Figure 19. DP9 and DS7 cells fail to differentiate under different adipogenic conditions. 
When exposed to a different adipogenic medium, DS7 cells (B) failed completely to 
accumulate intracellular lipids at two initial seeding densities, while DP9 cells (A) 
accumulated a very low but detectable level. No spontaneous differentiation occurred after 
six days of control growth medium. 
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Adult stem cells that overexpress either wild type lamin A or two lamin A 
mutants inhibits their ability to accumulate intracellular lipids. 
It has been suggested that adult stem cells may be implicated in laminopathies by failing 
to differentiate and thus ultimately failing to regenerate new tissue (Hutchison and 
Worman 2004; Markiewicz eta!., 2005). To test this hypothesis, three clones of DP9 cells 
overexpressing either FLAG-prelamin A, FLAG-prelamin M50, or FLAG-prelamin 
A(R644C) were subjected to adipogenic conditions for six days, fixed and stained for 
intracellular lipid accumulation with oil red-O. All nine clones failed to accumulate the 
same level of intracellular lipids as the untransfected DP9 cells (Figure 20A). DP9 cells 
overexpressing wild type FLAG-prelamin A all had similarly low levels of intracellular 
lipid accumulation. In contrast, DP9 cells overexpressing FLAG-prelamin M50 or 
FLAG-prelamin A(R644C) were more variable, albeit at a level still far below the 
untransfected DP9. Interestingly, one clone overexpressing FLAG-prelamin M50 failed 
to accumulate any intracellular lipids at all (Figure 20A 5Cl). 
Semi-quantitative analysis of the nine clones by spectrophotometric measurement of the 
extracted oil red-O revealed a significant reduction in the ability of cells to differentiate, as 
compared to untransfected DP9 cells (Figure 20B). DP9 cells stably expressing FLAG-
prelamin AL\50 showed the greatest reduction with an 80% decrease in differentiation 
potential (Mean 20%; SD ± 17.4% [n=3]). The large standard deviation for the pooled 
FLAG-prelamin M50 data may be the accounted for by clone 5C 1, which failed to 
differentiate at all (Figure 20A 5CJ). DP9 cells stably expressing FLAG-prelamin A wild 
type had a 77% reduction in differentiation potential (Mean 23%, SD ± 2.3% [n=3]), 
whilst cells stably expressing FLAG-prelamin A(R644C) had a 64% decrease in 
differentiation potential (Mean 36%, SD ± 3.9% [n=3]). All three stable lines showed a 
statistically significant difference in differentiation potential compared to untransfected 
DP9 cells, based on a Student's t-test: WT (P<0.0001); L\50 (P<0.01); R644C (P<O.OOl). 
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Intracellular lipid accumulation followed a similar distribution to that observed for 
untransfected DP9 and DS7 cells, with non-uniform localised areas of lipid accumulation, 
whilst some areas showed no accumulation of lipids at all (Figure 20C). Taken together, 
these results show that intracellular lipid accumulation is inhibited in stably-expressing 
cells, which suggests that continued overexpression of wild type or mutant lamin A 
inhibits the ability of adult stem cells to differentiate in vitro towards an adipogenic 
lineage. This result confmns an earlier report whereby wild type and mutant lamin A 
FLAG-tagged constructs that were overexpressed in 3T3-Ll preadipocytes led to the 
inhibition of intracellular lipid accumulation, although the mutant lamins were based on 
mutations found in FPLD patients (Boguslavsky et al., 2006). 
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Figure 20. Overexpression of lamin A and two mutants associated with premature aging 
inhibits the ability of adult stem cells to accumulate intracellular lipids. Stable DP9 cells 
overexpressing wild type FLAG-LA, FLAG-LM50 or FLAG-LA(R644C) were grown 
for six days under adipogenic conditions and stained for intracellular lipid accumulation 
with oil red-O (A). Oil red-O was extracted and the percentage of differentiation of three 
clones for each construct was expressed as a percentage of the total differentiation attained 
by untransfected DP9 (B). * Significantly reduced differentiation potential: WT 
(P<O.OOOl); ~50 (P<O.Ol); R644C (P<O.OOl). Non-uniform distribution of oil red-O 
staining after six days of adipogenic conditions reveals localised areas of differentiation in 
all but one of the nine clones tested (C). (Scale 200j.llll) 
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Establishment of an antibiotic-inducible gene expression system for the 
controlled expression of FLAG-tagged lamin A, lamin AL150 and lamin 
A(R644C). 
As DP9 cells are transformed, their number should remain constant with serial passage; 
indeed, growth potential results confirm this (Figure 17). Therefore, DP9 cells were seen 
as an ideal model for an adult stem cell system in which to introduce a Tet-On Advanced 
gene expression system. This is a valuable tool with which to modulate expression levels 
and is particularly useful when the protein of interest is toxic to the cell, i.e. progerin, and 
can be used to follow cell cycle phenotypes in a single clone expressing different levels of 
the protein (Glynn and Glover, 2005; Domer et al., 2006; Shumaker et al., 2006). 
Following a double-stable transfection and selection process, the system itself permits 
gene expression to be tightly regulated in resp~nse to varying concentrations of antibiotic. 
In order to determine the concentration of doxycycline with which to induce gene 
expression, a luciferase assay was carried out to measure activity over a range of 
concentrations. The cell line used was U2-0S Luc Tet-On Advanced (as supplied by 
Clontech), an osteosarcoma cell line containing wild type p53 but with the overexpression 
of the p53-inhibitor Mdm2 (Nelissen et a/., 2000), that has been previously stably 
transfected with the Tet-On Advanced luciferase construct. The lowest concentration of 
doxycycline required to induce expression in these cells after 48 hours was 1 Ong/ml 
(Figure 21 ). Additionally, prior to beginning the first stable transfection, a fixed number of 
DP9 cells were subjected to various concentrations to hygromycin Band G418 in order to 
determine the optimal concentration for selection of DP9 cells (data not shown). The 
optimal concentration of hygromycin B was found to be 1 OOJlg/ml and G418 400Jlg/ml. 
Thereafter, the optimal plating density for which cells should be plated for stable selection 
was then determined and judged to be 5 x 105 (Figure 22). Further preliminary work 
included cloning ATG-FLAG-prelamin A wild type, ~50 and R644C into the pTRE-Tight 
vector to be used for the second stable transfection. 
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Figure 21. DP9 dose-response curve. Increasing concentrations of doxycycline was added 
to U2-0S Luc Tet-On Advanced cells and then assayed for luciferase activity after 48 
hours. 
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Figure 22. Determination of DP9 optimal plating density. After an optimum concentration of hygromycin B and geneticin were found, 
lOOJ!g/ml and 400J.!g/ml respectively, DP9 cells were plated at three different cell densities and grown for a number of days to 
determine the number to be plated for stable selection. 
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The first stable transfection was then performed with the pTet-On Advanced construct, 
selected in G418, with 24 clones propagated. Expression levels of the rtTA-Advanced 
protein were assayed by Western blot analysis with a monoclonal antibody specific to the 
rtTA-Advanced protein. A single clone (D3) was then identified that expressed the highest 
levels of the rtTA-Advanced protein and chosen for the second stable transfection (Figure 
23). Due to time restraint, the second stable transfection was not started and the cells 
frozen down. In time, these cells will provide a great opportunity to assess the pathology 
of overexpressing mutant lamin A in adult stem cells. 
1 2 3 4 
Figure 23. DP9 Tet-On Advanced clonal selection. DP9 cells were transfected with pTet-
On Advanced and selected in 400tJ.g/ml geneticin. Single clones were propagated and then 
assayed for the production of the pTet-On Advanced protein rtTA with the TetR 
monoclonal antibody at a dilution 1:2000. Lane 2, clone D3, showed the highest levels of 
rtTA expression and will be used for the second stable transfection for the Tet-On 
Advanced gene expression system. 
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Chapter 4. Discussion & Conclusion 
A functional lamina is required to maintain nuclear envelope structure in 
adult stem cells 
Here, it has been shown that transient overexpression of two mutants associated with 
typical and atypical HGPS in adult stem cells causes a variety of nuclear abnormalities 
(Figures 6 and 7). This supports a vast body of evidence whereby a host of laminopathy 
mutations give rise to nuclear abnormalities when primary cells are grown in vitro or cells 
are transiently transfected with expression plasmids harboring laminopathy mutations 
(Ostlund eta!., 2001; Raharjo et al., 2001; Vigouroux eta!., 2001; Novelli et al., 2002; 
Bechert eta!., 2003; Capanni eta/., 2003; Chen eta!., 2003; De Sandre-Giovannoli eta/., 
2003; Eriksson et al., 2003; Favreau eta!., 2003; Holt eta!., 2003; Mounkes eta/., 2003; 
Csoka et a/., 2004b; Goldman et a/., 2004; Muchir et al., 2004; Navarro et al., 2004; 
Reichart et al., 2004, Scaffidi and Misteli, 2005). How these nuclear envelope structural 
defects manifest themselves as the phenotypes associated with the various laminopathies 
is an area of ongoing research. The complexity of the INM has recently been shown to be 
greater than previously imagined and thus it is likely that different laminopathy mutations 
result in different disease mechanisms that govern the phenotype (Schirmer eta!., 2003). 
The observed nuclear abnormalities found in laminopathy cells has prompted the 
suggestion that one such disease mechanism is based on the role of lamins as a tensegrity 
element, a vital underlying structural support of the nucleus (Hutchison et al., 2001; 
Wilson et al., 2001; Burke and Stewart, 2002; Goldman et al., 2002; Hutchison and 
Worman, 2004). This 'structural' hypothesis is supported by evidence that cardiomyctes 
from LMNA-null mice leads to progressive cytoskeletal disorganisation with detachment 
of desmin filaments from the nuclear surface (Nikolova et al., 2004). Furthermore, 
mutations within nesprins are associated with EDMD, with cells exhibiting 
mislocalisation of emerin and SUN2 (Zhang eta!., 2007). The implication of this is that 
the LINC complex, connecting the nucleus to the cytoskeleton, may be disrupted by A-
type lamin mutations, leading to increased sensitivity to mechanical stress, especially 
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those cells that undergo physical forces such as cardiomyctes (Hutchison and Worman, 
2004; Burke and Stewart, 2006; Worman, 2006). Underlining this, LMNA-null MEFs 
show a decreased mechanical stiffness with increased nuclear deformation, defective 
mechanotransduction, impaired cellular viability under mechanical strain and an overall 
increase in cellular weakness (Broers et a/., 2004; Lammerding et a/., 2004). The 
enhanced nuclear fragility may help explain the cardiac and skeletal pathologies as the 
forces generated during muscle contraction may lead to the preferential breakage of nuclei 
containing a defective nuclear lamina. However, this structural hypothesis cannot underlie 
the dramatic phenotype seen in patients with typical and atypical HGPS, indeed, that 
LMNA-null MEFs show attenuated NF-KB signaling suggests that other mechanisms are 
involved in disease pathogenesis (Lammerding eta/., 2004). 
Evidence suggests that the incomplete processing of progerin and the retention of the 
farnesyl group may be a significant factor in the development of HGPS (Goldman eta/., 
2004; Glynn and Glover, 2005; Gruber et al., 2005; Toth et al., 2005; Yang et al., 2005). 
Indeed, the number of misshapen nuclei in fibroblasts from typical HGPS increases with 
passage number, which is correlated with the accumulation of progerin along the nuclear 
envelope (Goldman et al., 2004). Similarly, Zmpste24-null mice also exhibit misshapen 
nuclei and HGPS-like disease phenotypes, caused by accumulation of unprocessed 
farnesylated and carboxymethylated prelamin A (Bergo eta/., 2002; Pendas et al., 2002; 
Fong et al., 2004). This has led to the suggestion that progerin exerts a dominant negative 
effect in the nucleus and that prelamin A is toxic to cells, directly causing misshapen 
nuclei (Gruber eta/., 2005; Scaffidi and Misteli, 2005; Toth et al., 2005; Yang eta!., 
2005). The current worK: underpins this 'prelamin A toxicity' hypothesis, and shows for 
the first time that adult stem cells also exhibit nuclear abnormalities upon transient 
transfection with expression plasmids. However, the extent to which these nuclear 
abnormalities reflect the in vivo situation and contribute to the disease phenotype, rather 
than as an artefact of in vitro culture methods, remains to be seen. 
Nuclear aggregates of lamins have been widely reported previously for various lamin 
mutations (Schmidt et al., 1994; Izumi et al., 2000; Ostlund et al., 2001; Rahmjo et a/., 
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2001; Vaughan et al., 2001; Markiewicz et al., 2002b; Capanni et al., 2003; Holt et al., 
2003). In this study, transient overexpression of plasmids harbouring two premature aging 
mutants caused a degree of intranuclear aggregate formation. The observation that 
transient overexpression of LA(R644C) in DP9 cells caused the formation of more 
intranuclear aggregates than LM50 is puzzling. The mutant protein formed by the 
LA(R644C) mutation is expected to be both famesylated and carboxymethylated, 
therefore rendering it likely to associate with the INM due to its lipid anchor, as is the case 
for LAL\50. Studies using famesyl transferase inhibitors (FTis) to treat primary HOPS 
fibroblasts and MEFs from a HOPS mouse model have shown that blocking lamin A 
biogenesis at the first stage, i.e. blocking famesylation, leads to the relocalisation of 
progerin away from the nuclear envelope into nucleoplasmic aggregates, normalising 
nuclear envelope shape (Toth et al., 2005; Yang et al., 2005). This is in accordance with 
previous work showing that in mevinolin treated HEp-2 cells the blocking of famesylation 
causes prelamin A to accumulate in intranuclear foci, with the suggestion that these foci 
may be the site of lamin A-heterochromatin formation before subsequent targeting of 
prelamin A to the nuclear envelope that would help to reorganise the three dimensional 
structure of chromatin (Sasseville and Raymond, 1995). Furthermore, it has been 
suggested that famesylation occurs at nucleoplasmic foci (Lutz et al. 1992, Moir et al. 
1995). Lamin A microinjected into 3T3 cells accumulates into intranuclear foci before 
gradually integrating into the nuclear lamina (Goldman et al., 1992). In the current study, 
it would be predicted that these intranuclear aggregates would have undergone the 
famesylation processing step, however, their location in the nucleoplasm suggests 
otherwise. One might postulate that the overexpression of prelamin A, which exists only 
transiently in wild type cells with a half-life of 90-100 minutes, might accumulate by 
binding to itself (Gerace et al., 1984; Beck et al., 1990). Taken together, if mutant 
prelamin A were to follow a similar spatial processing pathway then the intranuclear 
aggregates may arise by failure to be shuttled to the nuclear periphery for integration into 
the nuclear lamina. Support of this comes from FRAP studies, suggesting that progerin is 
less mobile in the nucleus (Dahl et al., 2006). However, a more detailed study using a 
panel of prelamin A antibodies would clarify the nature of these intranuclear aggregates. 
Some insight may be gained from a previous report that has shown that overexpression of 
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dominant negative lamin NC mutant mutants causes the redistribution of lamin B 1 and 
endogenous lamin NC into intranuclear foci together with the mutant lamin NC, yet there 
still remained traces of lamin B 1 and endogenous lamin NC at the nuclear periphery 
(Ostlund et al., 2001). Moreover, emerin, an A-type lamin binding partner, was 
mislocalised away from the INM (Ostlund et al., 2001). The current study has shown that 
the formation of intranuclear lamin aggregates does not mislocalise emerin away from the 
INM (Figure 11 ). This suggests that endogenous levels of lamin NC are not perturbed by 
the presence of these aggregates, although further work is required to reveal the 
distribution of endogenous lamin NC and lamin B 1 in cells with intranuclear lamin 
aggregates. 
In this study, it has been shown that LA~SO and LA(R644C) were targeted to the nuclear 
envelope in the majority of cells as they are both expected to retain their farnesyl anchor 
due to the deletion of, or mutation in, respectively, the second endoproteolytic Zmpste24 
cleavage site (Figure 7) (Goldman et al., 2004; Dechat et al., 2007). The most common 
nuclear abnormality observed was a transnuclear lamin structure (Figure 8). Analysis of 
these structures revealed that these are deep extensions of the nuclear envelope rather than 
accumulation of lamin protein within the nucleoplasm. Further evidence suggesting these 
are continuous extens,ion of the nuclear envelope is supported by the colocalisation with 
the INM protein emerin (Figure 11 ). The observation that they are extensions of the 
nuclear envelope may be accounted for by the presence of the farnesyl motif, which is 
expected to locate progerin to the INM during interphase (Goldman et al., 2004). Previous 
reports have shown that over-expression of prenylated lamins in cells induces excessive 
nuclear membrane formation and growth (Prufert et al., 2004; Raile et al., 2004). Based 
on this, it has since been suggested that the continued presence of progerin at the INM is 
responsible for the characteristic nuclear blebbing due to excessive nuclear membrane 
growth (Goldman et al., 2004; Capell et al., 2005). Work presented here supports this, as 
nuclear blebbing was observed in some cells and, additionally, the transnuclear lamin 
structures observed could conceivably be the precursor for more pronounced nuclear 
blebbing over time. However, the majority of cells retained a normal nuclear envelope 
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structure with the mutant prelamin A being incorporated into the nuclear envelope, which 
suggests that nuclear blebbing may not be the major determinant in disease pathogenesis. 
Premature aging mutations inhibit the self-renewal capacity of adult stem 
cells 
The present work has shown that the continued overexpression of mutant prelamin A has a 
negative effect on the growth potential of DP9 cells in vitro (Figure 17). This implies that 
self-renewal of adult stem cells may be inhibited in somatic tissues in laminopathy 
patients. Before discussing the potential implication for this, it is important to underline 
that further work is required to clarify this finding, either through a suitable apoptotic or 
senescence assay. Furthermore, the level of overexpression in the nine cell lines (three 
each of LA, LM50 and LA(R644C)) used needs to be quantified, either at the mRNA or 
protein level. Despite this, it is tempting to speculate as to the effect that a diminished 
number of adult stem cells may have on tissue regeneration. A previous report of a mouse 
model for HGPS has shown that continued culture of LMNAL5JOP!LSJOP adult fibroblasts 
resulted in apoptosis rather than senescence with no differences in telomere length 
between wild type and LMNALSJOP!LSJOP mice (Mounkes et al., 2003). Routine passage of 
primary human HGPS fibroblasts leads to increased proliferation rate during early passage 
numbers followed by a dramatic decrease as a result of apoptosis and/or senescence 
(Bridger and Kill, 2004; Goldman et al., 2004). These results suggest a loss of cell cycle 
control in early passage number HGPS fibroblasts, probably via Rb-dependent pathways 
(Mancini et al., 1994; Ozaki et al., 1994; Markiewicz et al., 2002b; Bridger and Kill, 
2004; Nitta et al., 2006). With an increase in DNA damage in HGPS, it could be 
suggested that genomic instability as a result of deregulated cell cycle control may 
promote entry into senescence (Liu et a/., 2005). This premature entry into senescence is 
inextricably linked to the presence of the famesylated prelamin A mutant (Bridger and 
Kill, 2004; Goldman et al., 2004; Caron et al., 2007). Strengthening this link, Rb has been 
shown to be involved in cellular senescence as it is upregulated by the tumour suppressor 
pl6INK4A and believed to form repressive heterochromatin loci containing E2F targets 
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(Campisi, 2005). It is also feasible that senescence may be achieved via a p53-dependent 
pathway (Campisi, 2005). Underlining this, lamin A/C is activated in a p53-dependent 
manner in cells responding to DNA damage, and Zmpste24-null MEFs show upregulation 
of p53 (Varela et al., 2005; Rahman-Roblick et a/., 2007). Although there is a putative 
p53-binding site in intron 1 of lamin A/C, it has been suggested that downstream effectors 
such as p21CDKNI maybe involved in the senescence process ofHGPS (Cox and Faragher, 
2007; Rahman-Roblick eta/., 2007). 
On the other hand, as opposed to either Rb or p53-dependent senescence, replicative 
senescence is linked to telomere shortening (Faragher and Kipling, 1998). One report has 
shown that telomere length is reduced in primary HGPS fibroblasts (Allsop et al., 1992). 
In addition, whilst a subset of dermal fibroblasts from HGPS patients may be 
immortalised by telomerase expression, more detailed analysis showed that some clones 
retrovirally infected with hTERT fail to immortalise (Ouellette et al., 2000; Wallis et al., 
2004). This is in contrast to reports of LMNALSJOP!LSJOP adult fibroblasts where no such 
telomere shortening was observed (Mounkes eta/., 2003). This apparent difference may 
be due to fundamental differences between mouse/rat and human cells, underlined by the 
mouse model of HGPS whereby a homozygous L530P mutation causes disease 
pathogenesis, rather the classical heterozygous G608G mutation found in humans. Thus, it 
is conceivable that senescence may by driven by telomere shortening in HGPS patients 
but is unlikely in mice. 
An important derivation from the above, and in line with the current work, might then 
implicate the senescence of stem cells not only in premature aging, but also in the normal 
aging process. Indeed, p 16INK4A expression limits the regenerative capacity of pancreatic 
~-cells with aging (Krishnamurthy et a/., 2006). Evidence also suggests that p16INK4A 
expression increases with age in HSCs, which causes cellular and molecular 
hematopoietic stem cell aging (Beausejour and Campisi, 2006; Janzen eta/., 2006; Rossi 
eta/., 2007). Furthermore, skeletal muscle satellite cells show an age-related decrease in 
differentiation potential (Lees et al., 2006). The proposed effect of age-related changes in 
adult stem cell acts at both the self-renewal and differentiation level. The current work 
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highlights that prelamin A mutations inhibit the in vitro replication of adult stem cells, 
which suggests that their ability to self-renew is diminished. As well as proliferation data, 
transient overexpression of prelamin A mutants resulted in structural defects, such as 
binucleated cells and micronuclei. The colocalisation of emerin with mutant lamin A in 
the micronuclei suggests that the mutant lamin A was first incorporated into the lamina 
before subsequently being 'expelled' out of the parent nuclei. It seems likely that 
complications during mitosis may cause these defects. Recent reports from two groups 
have elucidated the defects associated with HGPS during mitosis (Cao et al., 2007; Dechat 
et al., 2007). 
Progerin perturbs the cell cycle at multiple stages. Whilst lamin A solubilises freely during 
mitosis, progerin assembled into insoluble cytoplasmic aggregates and associated with 
membrane-like network structures, as evidenced by its FLIP (fluorescence loss in 
photobleaching) data and its colocalisation with emerin and lamin B (Cao et al., 2007; 
Dechat et al., 2007). Progerin also caused an increase in lagging chromosomes at 
anaphase and this was reflected by the increased time the cells spent in late mitosis. This 
delay in resolving lagging chromosomes also delays cytokinesis and the targeting of 
nuclear envelope components to daughter cell nuclei in late telophase/early G1, which in 
turn may cause binucleated cells (Cao et al., 2007; Dechat et al., 2007). It was also 
suggested that an absence of phosphorylated Rb in highly lobulated HGPS cells might be 
due to the inhibition of cyclin D-cdk 4,6 by p16INK4A, which is an attractive hypothesis as 
p 16INK4A expression limits the regenerative capacity, as described previously. Therefore, 
combined with mitotic defects, this will invariably drive cells towards either apoptosis or 
senescence (Cox and Faragher, 2007). The potential consequence of this is damage to the 
microenvironment, which may then contribute to age-related decline in tissue function 
(vanZant and Liang, 2003; Campisi, 2005, Carlson and Conboy, 2007). The current work 
showed reduced levels of Rb phosphorylated at serine 807/811 in DP9 cells transfected 
with prelamin A R644C constructs, and may reflect the induction of a cell cycle arrest, 
resulting in loss of phosphorylated Rb. Intimately linked to this, the role of LAP2a in the 
self-renewal of adult stem cells also requires further investigation, as previous reports 
> have shown that lamin A/C-LAP2a-Rb complexes exist in the nucleoplasm and act to 
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control cell cycle progression (Dechat et al., 2000a; Markiewicz et al., 2002b; Domer et 
al., 2006; Pekovic et al., 2007). The current report showed that LAP2a distribution is not 
affected by either premature aging mutant at the confocal microscopic level (Figure 12). 
Previous studies have shown that overexpression of lamin mutants can cause LAP2a 
mislocalisation into intranuclear aggregates, however, there were no such observations 
here (Dechat et al., 2000a; Markiewicz et al., 2002b). This may be accounted for by the 
type of construct used. Previous studies have used lamin B 1 mutations, and since A-type 
lamins are dependent on functional B-type lamins for nuclear lamina incorporation, then 
the intranuclear aggregates formed by these mutations have disrupted endogenous lamin 
NC and caused the redistribution of LAP2a into these aggregates (Dyer et al., 1999; 
Dechat et al., 2000a; Izumi et al., 2000; Markiewicz et al., 2002b). As no obvious effect 
was seen here, further in vitro binding assays might clarify the nature of the 
LA~50/LA(R644C)-LAP2a interaction, whilst it might be of note to observe its 
localisation with serial passage and perhaps its ability to maintain lamin binding with 
passagmg. 
Prelamin A inhibits the differentiation potential of adult stem cells 
The current work shows that stable overexpression of lamin A and two mutants associated 
with premature aging causes the inhibition of multipotent adult stem cells to differentiate 
in vitro. Before discussing how this might occur in the context of this and other work, 
there are some noteworthy points regarding these results. Firstly, that the use of a different 
adipogenic medium may affect the ability of adult stem cells to accumulate intracellular 
lipids (Figure 18 and 19). Although this has no significant bearing on the validity of the 
results obtained with a different adipogenic medium, it does suggest that the in vitro 
medium is crucially important and serves as a potential warning for future work and for 
other reports. Indeed, it has been shown that the percentage of nuclear abnormalities found 
in AD-EDMD fibroblasts vary significantly depending on the culture medium used (Holt 
et al., 2006). Taken together, these results suggest that in vitro results may not always 
accurately represent the in vivo situation. The difference between the two adipogenic 
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media was rabbit serum and the concentration of dexamethasone, which was ten times less 
in the medium with rabbit serum (Jahoda et al., 2003; Boguslavsky et al., 2006). Whether 
it was the presence/absence of the rabbit serum or concentration of dexamethasone that 
affected lipid accumulation remains to be seen. The current results are supported by 
previous data showing that overexpression of lamin mutations causes the inhibition of 
differentiation in satellite cells and preadipocytes (Favreau et al., 2004; Markiewicz et al., 
2005; Boguslavsky et al., 2006; Frock et al., 2006). However, these results are directly 
contradicted by one paper suggesting that overexpression of both wild type lamin A and 
lamin A harboring FPLD mutations had no effect on the ability of 3T3-Ll cells to 
differentiate (Kudlow et al., 2005). During the differentiation assays this group removed 
the selective agent against the expression plasmid (Kudlow et al., 2005). However, the 
counter argument against these fmdings is that differentiation assays were carried out in 
multiple clonal populations of 3T3-Ll cells, obtaining similar results with these and an 
MEF model (Boguslavsky et al., 2006). To add further transparency to these results, it 
might be prudent to examine whether after six days in growth medium stably transfected 
DP9 cells still express FLAG-prelamin A, ~50 or R644C to the same extent as when 
grown for six days in the presence of the selection agent, hygromycin B. If they do, then 
the cells could be subjected to an adipogenic medium for six days without the presence 
hygromycin B, which would then clarify if the presence or absence of the antibiotic plays 
any importance in the differentiation process. More importantly, the immediate questions 
that need to be addressed then is why overexpression of both wild prelamin A and 
prelamin A harboring premature aging mutants results in the inhibition of adult stem cell 
differentiation, whether they work by the same mechanism and what is the likely effect in 
vivo for HGPS patients. 
Adipogenesis is initiated by the rapid and transient increase of two transcription factors, 
C/EBP-P and -cS, which are members of the bZIP family of CCAAT/enhancer binding 
proteins (C/EBPs) (Darlington, 1998; MacDougald and Mandrup, 2002; Feve, 2005; 
Rosen, 2005; Ailhaud, 2006; Bengoechea-Alonso and Ericsson, 2007). This is followed 
rapidly by the expression of C/EBPa, and by the nuclear hormone receptor peroxisome 
:~ proliferator-activated receptor y (PPARy) (Spiegelman et a!., 1997). These two factors 
Ill 
remain elevated for the rest of the differentiation process activating their own and the 
other's expression (Rosen et a/., 2002). Furthermore, the helix-loop-helix (HLH) factor 
SREBP1c has been shown to be highly expressed in adipocytes, and to promote 
differentiation when over-expressed (Tontonoz eta/., 1993; Kim and Spiegelman, 1996; 
Brown and Goldstein, 1997; Kim et a/., 1998). This may occur in part through direct 
actions of SREBP1c on target promoters including that of PP ARy and also indirectly by 
inducing the generation of a ligand for PP ARy (Fajas eta/., 1999). It has been suggested 
that the lipodystrophy associated with HOPS may be explained by comparisons to another 
laminopathy that shows adipose tissue defects, FPLD. Mutations found in FPLD are 
located in the C-terminal near a solvent-accessible area of the immunoglobulin-like fold, 
suggesting that these mutations may alter an interaction with a specific binding partner 
(Dhe-Paganon eta/., 2002; Krimm eta/., 2002). MADA and atypical WS patients also 
have an associated lipodystrophy, and it has been shown that a percentage of cells from 
these patients show an accumulation of prelamin A (Capanni et a/., 2005). This is 
important because it has been shown that SREBP 1 c binds to prelamin A, but not mature 
lamin A or C in vivo (Capanni et a/., 2005). Therefore, a mechanistic basis for the 
pathology of lipodystrophy found in FPLD, MADA and atypical WS is suggested 
whereby activation of SREBP1c causes its subsequent translocatation to the nucleus, but 
with accumulation of prelamin A at the nuclear envelope its causes the sequestration of 
SREBP1c away from the nuclear interior, in tum impairing the PPARy-dependent 
adipogenesis (Brown and Goldstein, 1997; Capanni et a/., 2005; Filesi et a/., 2005; 
Maraldi eta/., 2006a,b; Maraldi eta/., 2007a,b). This mechanism for disease pathogenesis 
is an attractive proposal for FPLD and indeed for the lipodystrophy associated with 
HOPS, however, at present there is no other evidence that the accumulation of prelamin A 
affects lamin binding partners of other tissues affected in HOPS, and thus does not serve 
as a general theorem to explain the far more drastic phenotype of HOPS as compared to 
FPLD. Cell lines from other tissues affected by HOPS might be examined in a yeast two 
hybrid screen with the C-terminal of progerin as bait, similar to previous work that first 
identified SREBP1c as a laminA binding partner (Lloyd eta/., 2002). 
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In contrast to this hypothesis, the involvement of Rb in adipogenesis and myogenesis 
implicates a different pathogenic mechanism for cellular differentiation defects in 
laminopathies. Terminal differentiation requires the permanent withdrawal from the cell 
cycle and the expression of specific genes. Early in adipogenesis, Rb is 
hyperphosphorylated, corresponding to the period of clonal expansion, and soon thereafter 
it becomes hypophosphorylated, accumulating to prevent reentry into the cell cycle and 
promote terminal differentiation (Puigserver et al., 1998; Classon et al., 2000). 
Heterodimeric cyclin and cyclin-dependent kinases (CDKs) complexes phosphorylate RB, 
allowing G1~S phase transition, and cyclin-dependent kinase inhibitors (CKis) modulate 
CDK activity. At the onset of adipogenesis, as well as activating adipogenic-specific 
transcription, C/EBP-P and --D proteins stimulate CDK inhibitor p21 expression by 
directly binding its the promoter region, leading to the inhibition of CDK-mediated 
retinoblastoma protein (Rb) phosphorylation, resulting in cell cycle exit (Chen et al., 
1996; Timchenko et al., 1996; Puigserver et al., 1998; Johnson, 2005). Rb can also inhibit 
adipogenesis via recruiting HDAC to PP ARy promoters, helping to regulate temporal 
expression of adipogenic genes and also acts as a molecular switch, determining white 
versus brown adipose tissue formation (Fajas et al., 2002; Hansen et al., 2004). 
Rb is also critical for myogenesis, during which nucleoskeleton remodeling is required for 
effective adult muscle satellite stem cell differentiation (Novitch et al., 1996; Novitch et 
al., 1999; Mariappan and Parnaik 2005; Markiewicz et al., 2005). A previous report has 
shown that lamin A and lamin C is relocated from the nucleoplasm to the nuclear 
periphery during myogenesis (Markiewicz et al., 2005). The authors suggest that 
expression of mutant laminA inhibits C2C12 differentiation because it may maintain or 
enhance lamin A/C-LAP2a associations, therefore causing inhibition of a fully functional 
Rb that is required for entry into a postmitotic state (Markiewicz et al., 2005). Lamin A/C 
has been shown to interact with chromatin at the periphery and the nucleoplasm, thus the 
consequence of remodeling the nuclear lamina during differentiation may lead to the 
relocation of specific chromatin to the periphery of the nucleus, a location associated with 
gene silencing, and thus silencing genes necessary to maintain the differentiated cell state 
(Moir et al., 1995; Goldman et al., 2002). Therefore, applying this to the current work 
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suggests that premature aging mutants inhibit remodeling of the nucleoskeleton in adult 
stem cells, causing a failure to differentiate. In this study, transient transfection revealed 
no obvious LAP2a defects, although further work might seek to elucidate properties of 
endogenous lamin A/C, lamins Bl/B2 and LAP2a during adipogenic differentiation, as it 
has previously been shown that overexpression of LAP2a causes cell cycle exit and 
enhances differentiation by binding hypophosphorylated Rb (Domer et a!., 2006). 
Therefore, it could be suggested that premature aging mutants may have a dominant 
negative effect in this lamin A/C-LAP2a-Rb complex, leading to inefficient cell cycle 
arrest required for differentiation. Moreover, if this was the case it may help to explain the 
senescent phenotype as the lamin A/C-LAP2a-Rb complex is required for correct 
progression into S-phase, and if this complex is affected by premature aging mutants then 
it is possible that cells prematurely enter into S-phase, with a concomitant accumulation of 
DNA damage, resulting in eventual cellular senescence. Taken together, the finding that 
premature aging mutants cause the inhibition of adult stem cell differentiation suggests 
that ineffective regeneration of tissue in HGPS patients may be an underlying and 
important cause of the disease pathogenesis. 
A recent paper has shown that the famesylated and carboxymethylated human prelamin A 
C-terminal peptide that is normally cleaved by Zmpste24 in the last step in prelamin A 
processmg induces mitotic arrest, muscle-specific gene expression, and myotube 
formation, thereby acting as a signal for differentiation (Brodsky et al., 2007). 
Furthermore, it is involved in physically separating DNA into distinct globular chromatin 
domains (Brodsky et al., 2007). Taken together, these results suggest for the first time that 
the prelamin A processing by-product has a function within the nucleus and may help to 
explain the conserved mechanism of prelamin processing steps. Moreover, lamin A 
mutants that cannot undergo this last processing step cannot release the peptide and 
therefore are inhibited to differentiate, which is in line with the work presented here as 
both LM50 and LA(R644C) are expected to remain famesylated and carboxymethylated 
without the fmal Zmpste24 cleavage step (Brodsky et a!., 2007). 
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Pathogenic mechanisms for laminopathies: potential role of adult stem cells 
In light of previous reports that have shown that there exists a population of human 
multipotent adipose-derived stem cells (hMADs ), it may be suggested based on the data 
presented here that the lipodystrophy associated with HGPS may be attributed to the 
failure of these hMADs to effectively regenerate new tissue (Zuk et al., 2001; Zuk et al., 
2002; Rodriguez et al., 2004). Secondly, the results may be applied to the alopecia 
associated with HGPS patients to suggest that hair follicle stem cells fail to regenerate in 
this highly cycling appendage. Hair follicle development is not affected during 
development and alopecia presents during early childhood in patients with HGPS (Sarkar 
and Shinton, 2001). In line with this, A-type lamins are developmentally regulated and are 
most highly expressed in differentiated cells (Hutchison and Worman, 2004). Therefore, 
the expression of mutant lamin A coincides with hair follicle decline, which is associated 
with adult stem cell failure. Although this report has shown that overexpression of A-type 
lamin mutants inhibits the growth potential of adult stem cells, and possibly promotes 
subsequent entry into apoptosis and/or senescence, it could be suggested that the greater 
factor in tissue decline is likely to be made by the failure of adult stem cells to regenerate 
rather than to proliferate, as adult stem cells rarely undergo mitosis in vivo (Ma et a!., 
2004; Nystul and Spradling, 2006; Waters et al., 2007). 
The tissues affected in laminopathies are mesodermal in origin (Hutchison and Worman, 
2004). Therefore, it is plausible that adult stem cell niches may be affected by the 
mutations found in other laminopathies at the level of differentiation and proliferation, and 
may exhibit phenotypes that a resultant from stem cell failure to regenerate new tissues 
(Wagers and Weissman, 2004; Nystul and Spradling, 2006). However, as there is no 
specific genotype-phenotype relationship of the locations of the mutation within lamin 
AIC, i.e. not all may affect adult stem cells, then the disease phenotypes are likely to arise 
via a number of disease mechanisms, which may be attributed to defects in the main roles 
of lamins, namely, genomic caretaker, tensegrity element, transcriptional regulator and 
chromatin scaffold (Broers et al., 2006; Verstraeten et al., 2007). 
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The study of HGPS has been used to draw comparisons to the normal aging process. 
HGPS fibroblasts show a loss of peripheral heterochromatin and a loss of epigenetic 
modification regulation (Goldman et al., 2004; Shumaker et al., 2006). This loss of 
epigenetic regulation is comparable to nuclei from aged individuals, which also show 
nuclear abnormalities that are characteristic of HGPS cells, suggesting a link between 
premature and normal aging (Scaffidi and Misteli, 2005). Further studies revealed that the 
cryptic splice site that is activated in HGPS via the G608G mutation is actually activated 
in fibroblasts from normal control fibroblasts (Scaffidi and Misteli, 2006). It was also 
shown that the amount of progerin did not accumulate over time with serial passaging or 
between young and old individuals, in contrast to HGPS fibroblasts (Goldman et al., 2004; 
Scaffidi and Misteli, 2006). The implication of this is that there may be a minimum 
progerin tolerance, and this prolonged exposure over time may contribute to the normal 
aging process (Scaffidi and Misteli, 2006). 
Various reports have shown that it is the famesylation of progerin that makes it 
fundamentally toxic to cells (Capell et al., 2005: Glynn and Glover, 2005; Gruber et al., 
2005; Mallampalli et al., 2005: Toth et al., 2005; Yang et al., 2005). Previous work with 
Zmpste24-null mice drew the same conclusion, and mice were bred to reduce the prelamin 
A production in half by creating a Zmpste24_1_ LMNA+I- genotype, which in tum reduced 
the number of cells with nuclear defects, unequivocally implicating famesyl prelamin A as 
a toxic agent (Bergo et al., 2002; Pendas et al., 2002; Fong et al., 2004). Since then 
several reports have sought to reverse the cellular phenotype in the hope of eventual 
holistic disease amelioration. The first approach is based on blocking the famesylation of 
progerin by treating cells with a famesyl transferase inhibitor (FTI), which has been 
shown to reduce nuclear abnormalities by targeting progerin away from the nuclear 
envelope and into nucleoplasmic aggregates, and also improved whole organism 
phenotypes in two mouse models (Capell et al., 2005: Glynn and Glover, 2005; 
Mallampalli et al., 2005; Toth et al., 2005; Yang et al., 2005; Fong et al., 2006; Yang et 
al., 2006). Despite the doubts that still remain as to the effect that prolonged FTI exposure 
will have on cells, clinical trials with HGPS patients began in May 2007 and represents a 
> great and rapid success since LMNA was first identified as the causative gene in 2003 
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(Young et al., 2005; Meta et al., 2006; Rusinol and Sinensky, 2006; Young et al., 2006; 
Stewart et al., 2007). 
As HGPS fibroblasts show both total and focal loss of peripheral heterochromatin, 
attempts have been made to simultaneously block prelamin A famesylation and to rescue 
heterochromatin formation (Columbaro et al., 2005; Maraldi et al., 2006a,b; Maraldi et 
al., 2007a,b). The combination of mevinolin, to block famesylation, and trichostatin A, 
which inhibits histone deacetylase causing decondensation of chromatin domains, 
dramatically lowers progerin levels leading to rescue of heterochromatin organisation. 
Furthermore, intranuclear lamin A associated with splicing speckles was restored upon 
this dual treatment, which resulted in the reorganisation of transcripts in HGPS fibroblasts 
(Jagatheesan et al., 1999; Columbaro et al., 2005). 
In an alternative to drug treatment, the use of morpholino antisense oligonucleotides, 
designed to target the cryptic splice site activated in the de novo G608G mutation leads to 
a reversal of the cellular phenotype normally found in HGPS patients (Scaffidi and 
Misteli, 2005). Moreover, the use of the morpholino caused the correct expression of 
several misregulated genes discovered by microarray experiments (Ly et al., 2000; Csoka 
et al., 2004a; Scaffidi and Misteli, 2005). 
Use of short hairpin RNAi (shRNAi) designed to target the progenn mRNA for 
degradation also led to reduced progerin levels, reduced senescent staining, and 
significantly improved the replicative potential and nuclear morphology of HGPS 
fibroblasts (Huang et al., 2005). However, as yet there is no effective delivery mechanism 
that may allow shRNAs to reach the numerous tissues affected in HGPS, especially the 
arterial wall cells, which may play an important role in the pathogenesis of the accelerated 
atherosclerosis (Huang et al., 2005; McClintock et al., 2006). 
In light of the current work, future stem cell therapies should also be considered for the 
treatment of HGPS. This could be by replenishment with younger stem cells from healthy 
individuals. A potential problem to this method is underlined by evidence that an aged 
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microenvironment has a dominant negative effect on satellite stem cells, rather than 
intrinsic stem cell aging (Conboy et al., 2005; Rando, 2006; Rossi et al., 2007). Therefore, 
transplantation with healthy stem cells may be a futile exercise as the microenvironment 
ofHGPS patients is already prematurely aged. 
One possible avenue that may be explored for future stem cells therapies to treat HOPS is 
nuclear reprogramming, or de-differentiation, to generate an ESC-like cell from a somatic 
stem cell (Gurdon et al., 1958; Tada et al., 2001; Takashi and Yamanaka, 2006). The 
generation of new stem cells could be used to replenish the tissues in HOPS patients. 
Together with a low success rate for this method, the problem for HOPS patients would be 
finding a suitable somatic stem cell to reprogramme. Moreover, choice of a wrong one 
could actually deteriorate the tissue (Rosenthal, 2005). However, correction of nuclei from 
HOPS patients by drug treatment may reverse their cellular phenotype before initiating 
reprogrammmg. 
Despite potential problems, stem cell therapies are currently being employed to try and 
treat patients with a range of diseases, including vascular disease, myocardial dysfunction 
and osteogenesis imperfecta (Ho et al., 2005; Mauney et al., 2005; Bobis et al., 2006; 
Devogelaer and Coppin, 2006; Giordano et al., 2007; Pichinich et al., 2007). HOPS 
patients are now being treated with FTis, yet there remains the possibility that this 
treatment will not reverse all cellular and ultimately tissue defects, and as such, stem cell 
therapies directed towards treating HOPS might represent a realistic alternative. 
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